var title_f12_56_13184="EVAR with flared limb into the common iliac artery";
var content_f12_56_13184=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F68968&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F68968&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    EVAR with flared limb into the common iliac artery",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 228px; height: 355px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_56_13184=[""].join("\n");
var outline_f12_56_13184=null;
var title_f12_56_13185="Garden type I hip fracture";
var content_f12_56_13185=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F60318&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F60318&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Garden type I hip fracture",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 343px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Type I fractures can be incomplete, but much more typically they are impacted with a valgus and retroverted orientation.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Baumgaertner MR, Higgins TF. Femoral neck fractures. In: Rockwood and Green's Fractures in Adults, 5th ed, Bucholz RW, Heckman JD (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2002. Copyright &copy; 2002 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_56_13185=[""].join("\n");
var outline_f12_56_13185=null;
var title_f12_56_13186="M perstans microfilariae";
var content_f12_56_13186=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F83928&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F83928&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 535px\">",
"   <div class=\"ttl\">",
"    M. perstans microfilariae",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 515px; height: 260px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Microfilariae of Mansonella perstans are unsheathed and measure 190 to 200 micrometers in stained blood smears and 180 to 225 micrometers in 2% formalin. The tail is blunt, and nuclei extend to the tip of the tail. Microfilariae circulate in the blood.",
"    <br/>",
"    (A) Microfilariae of M. perstans in a thick blood smear stained with Giemsa from a patient from Cameroon.",
"    <br/>",
"    (B) Microfilaria of M. perstans in a thin blood smear from the same specimen as (A).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: Centers for Disease Control and Prevention. Parasites and Health: Filariasis. Available at:",
"     <a href=\"file://www.dpd.cdc.gov/dpdx/html/imagelibrary/a-f/filariasis/body_Filariasis_il10.htm\" style=\"font-style: italic;\" target=\"_self\">",
"      file://www.dpd.cdc.gov/dpdx/html/imagelibrary/a-f/filariasis/body_Filariasis_il10.htm",
"     </a>",
"     .",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_56_13186=[""].join("\n");
var outline_f12_56_13186=null;
var title_f12_56_13187="Rx psych side effects IFN";
var content_f12_56_13187=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F82012&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F82012&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 619px\">",
"   <div class=\"ttl\">",
"    Algorithm for pharmacological treatment of interferon-alfa-induced depression",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 599px; height: 730px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Raison, Charles L, Demetrashvili, Marina, Capuron, Lucile, Miller, Andrew H. Neuropsychiatric adverse effects of interferon-[alpha]: Recognition and Management. CNS Drugs 2005; 19:105. Copyright &copy;2005 Wolters Kluwer Health.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_56_13187=[""].join("\n");
var outline_f12_56_13187=null;
var title_f12_56_13188="Agalsidase beta: Patient drug information";
var content_f12_56_13188=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"0\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Agalsidase beta: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/34/8741?source=see_link\">",
"     see \"Agalsidase beta: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?33/37/34388?source=see_link\">",
"     see \"Agalsidase beta: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F130769\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Fabrazyme&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F854899\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Fabrazyme&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10011887\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700218",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Unsafe allergic effects may happen. Tell your doctor about any fever, rash, feeling tired, upset stomach, throwing up, loose stools, belly pain, flu-like signs, sore throat, cough, or trouble breathing. Do not restart this drug if you have had an allergic reaction.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10011889\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691839",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat Fabry disease.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10011888\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701447",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to agalsidase beta or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10011893\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10011894\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698082",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Flu-like signs while this drug is being given. These include headache, weakness, fever, shakes, aches, pains, and sweating. You may be given drugs before this shot to avoid these signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698133",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       High blood pressure during infusion.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698316",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Runny nose.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698350",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sore throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698360",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Swelling in the arms or legs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697983",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Cough.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698074",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling tired or weak.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10011896\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698626",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Chest pain or pressure.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699075",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of low mood (depression), thoughts of killing yourself, nervousness, emotional ups and downs, thinking that is not normal, anxiety, or lack of interest in life.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10011891\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695989",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into a vein over a period of time.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10011892\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696445",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Call your doctor for an office visit.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10011897\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699596",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug will be given to you in a hospital or doctor's office. You will not store it at home.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10011898\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11163 Version 34.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-61.234.146.186-6167F63EEA-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_56_13188=[""].join("\n");
var outline_f12_56_13188=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130769\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F854899\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10011887\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10011889\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10011888\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10011893\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10011894\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10011896\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10011891\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10011892\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10011897\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10011898\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?8/34/8741?source=related_link\">",
"      Agalsidase beta: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?33/37/34388?source=related_link\">",
"      Agalsidase beta: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f12_56_13189="ECG type II sinoatrial block";
var content_f12_56_13189=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F54936&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F54936&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1056px;\">",
"  <div class=\"figure\" style=\"width: 486px\">",
"   <div class=\"ttl\">",
"    Single-lead electrocardiogram (ECG) showing lead V5 in type II sinoatrial block",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 466px; height: 87px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    There is a 3:2 SA block, resulting in group beating of pairs of sinus beats. The P-P interval during the pause has a duration (1840 msec) that is approximately equal to two P-P cycles (920 msec); this finding distinguishes this arrhythmia from type I SA block in which the pause duration is less than that of two P-P cycles. There may be some sinus variability, as in this case, due to sinus arrhythmia and possibly to baroreceptor responses to varying diastolic filling intervals.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Morton Arnsdorf, MD.",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 450px\">",
"   <div class=\"ttl\">",
"    Normal rhythm strip",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 165px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Normal rhythm strip in lead II. The PR interval is 0.15 sec and the QRS duration is 0.08 sec. Both the P and T waves are upright.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Morton F Arnsdorf, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_56_13189=[""].join("\n");
var outline_f12_56_13189=null;
var title_f12_56_13190="Dyshidrotic eczema mild";
var content_f12_56_13190=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F83010&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F83010&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Dyshidrotic eczema",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    In mild forms of dyshidrotic eczema, tiny vesicles may be seen only on the lateral aspect of fingers.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_56_13190=[""].join("\n");
var outline_f12_56_13190=null;
var title_f12_56_13191="Endothelial dysfunction CHD I";
var content_f12_56_13191=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F52009%7ECARD%2F63805%7ECARD%2F77577&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F52009%7ECARD%2F63805%7ECARD%2F77577&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Coronary endothelial dysfunction",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 335px; height: 342px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Baseline arteriogram in a patient with early atherosclerosis and endothelial dysfunction.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Charles E Rackley, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Coronary endothelial dysfunction",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 340px; height: 339px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Infusion of acetylcholine, which is normally a vasodilatory, induces vasoconstriction in normal and abnormal arterial segments (arrows).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Charles E Rackley, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Coronary endothelial dysfunction",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 329px; height: 340px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    In comparison to acetylcholine, an infusion of nitroglycerin produces dilation in all segments.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Charles E Rackley, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_56_13191=[""].join("\n");
var outline_f12_56_13191=null;
var title_f12_56_13192="Clinical manifestations and diagnosis of central nervous system tumors in children";
var content_f12_56_13192=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"0\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Clinical manifestations and diagnosis of central nervous system tumors in children",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/56/13192/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/56/13192/contributors\">",
"     Ching Lau, MD, PhD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/56/13192/contributors\">",
"     Wan-Yee Teo, MBBS, MRCPCH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/56/13192/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/56/13192/contributors\">",
"     David G Poplack, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/56/13192/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/56/13192/contributors\">",
"     Melanie S Kim, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?12/56/13192/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 12, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Central nervous system (CNS) tumors include both nonmalignant and malignant tumors of the brain and spinal cord. Primary malignant CNS tumors are the second most common childhood malignancies, after hematologic malignancies, and are the most common pediatric solid organ tumor [",
"    <a class=\"abstract\" href=\"UTD.htm?12/56/13192/abstract/1\">",
"     1",
"    </a>",
"    ]. They are the leading cause of death from childhood cancer, surpassing the mortality rate of acute lymphoblastic leukemia [",
"    <a class=\"abstract\" href=\"UTD.htm?12/56/13192/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A general overview on the clinical manifestations and diagnosis of CNS tumors in children will be reviewed here. The clinical manifestations and diagnosis of the following specific CNS tumors that occur in children are discussed separately.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Low-grade gliomas (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?2/1/2071?source=see_link\">",
"       \"Diagnosis and classification of low-grade gliomas\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Malignant gliomas (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/60/35784?source=see_link\">",
"       \"Clinical manifestations and initial surgical approach to patients with malignant gliomas\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Medulloblastoma (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?40/23/41332?source=see_link\">",
"       \"Histopathology and molecular pathogenesis of medulloblastoma\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Craniopharyngioma (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/60/24520?source=see_link\">",
"       \"Craniopharyngioma\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Ependymoma (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?14/51/15161?source=see_link\">",
"       \"Ependymoma\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Focal brainstem glioma (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?39/40/40585?source=see_link\">",
"       \"Focal brainstem glioma\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Germ cell tumors (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?29/25/30105?source=see_link\">",
"       \"Pediatric intracranial germ cell tumors\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Intradural nerve sheath tumors, such as schwannomas, neurofibromas, and malignant peripheral nerve sheath tumors (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/1/28694?source=see_link\">",
"       \"Intradural nerve sheath tumors\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Meningioma (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?24/60/25540?source=see_link\">",
"       \"Meningioma: Clinical presentation and diagnosis\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Spinal cord tumors (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?6/63/7161?source=see_link\">",
"       \"Spinal cord tumors\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Tuberous sclerosis (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?33/38/34410?source=see_link\">",
"       \"Tuberous sclerosis complex: Genetics, clinical features, and diagnosis\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    An overview of the management and the epidemiology of CNS tumors in children are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/26/13736?source=see_link\">",
"     \"Overview of the management of central nervous system tumors in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/21/38230?source=see_link\">",
"     \"Epidemiology of central nervous system tumors in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;CNS tumors can produce symptoms and signs by local invasion, compression of adjacent structures, and increased intracranial pressure (ICP) by either a mass effect, which compresses normal CNS structures, or by causing obstruction of cerebrospinal fluid (CSF) flow, resulting in hydrocephalus.",
"   </p>",
"   <p>",
"    The presenting signs and symptoms of childhood CNS tumors vary with the child's age and tumor location, and are frequently subtle and nonspecific (",
"    <a class=\"graphic graphic_table graphicRef67480 \" href=\"UTD.htm?22/11/22715\">",
"     table 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef51623 \" href=\"UTD.htm?22/33/23067\">",
"     table 2",
"    </a>",
"    ). A systematic review analyzed 61 studies of 3702 children with CNS tumors (excluding cases of neurofibromatosis) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/56/13192/abstract/3\">",
"     3",
"    </a>",
"    ]. The following were the most common symptoms and their frequency:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Headache (33 percent)",
"     </li>",
"     <li>",
"      Nausea and vomiting (32 percent)",
"     </li>",
"     <li>",
"      Abnormal gait or coordination (27 percent)",
"     </li>",
"     <li>",
"      Papilledema (13 percent)",
"     </li>",
"     <li>",
"      Seizures (13 percent)",
"     </li>",
"     <li>",
"      Unspecified symptoms and signs of ICP (10 percent)",
"     </li>",
"     <li>",
"      Squint (7 percent)",
"     </li>",
"     <li>",
"      Change in behavior or school performance (7 percent)",
"     </li>",
"     <li>",
"      Macrocephaly (7 percent)",
"     </li>",
"     <li>",
"      Cranial nerve palsies (7 percent)",
"     </li>",
"     <li>",
"      Lethargy (6 percent)",
"     </li>",
"     <li>",
"      Abnormal eye movements (6 percent)",
"     </li>",
"     <li>",
"      Hemiplegia (6 percent)",
"     </li>",
"     <li>",
"      Weight loss (5 percent)",
"     </li>",
"     <li>",
"      Unspecified visual or eye abnormalities (5 percent)",
"     </li>",
"     <li>",
"      Altered level of consciousness (5 percent)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Infants and young children",
"    </span>",
"    &nbsp;&mdash;&nbsp;The distribution of symptoms changes in infants and young children because young children are unable to articulate symptoms (eg, such as headaches), and in infants, increased ICP is a late finding prior to the closure of the fontanelles and fusion of the sutures.",
"   </p>",
"   <p>",
"    A subanalysis of children BELOW 4 years of age with CNS tumors from the previously mentioned systemic review demonstrated a significantly different rank order of signs and symptoms as follows [",
"    <a class=\"abstract\" href=\"UTD.htm?12/56/13192/abstract/3\">",
"     3",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Macrocephaly (41 percent)",
"     </li>",
"     <li>",
"      Nausea and vomiting (30 percent)",
"     </li>",
"     <li>",
"      Irritability (24 percent)",
"     </li>",
"     <li>",
"      Lethargy (21 percent)",
"     </li>",
"     <li>",
"      Abnormal gait or coordination (19 percent)",
"     </li>",
"     <li>",
"      Weight loss (14 percent)",
"     </li>",
"     <li>",
"      Clinical hydrocephalus manifested by bulging fontanelle and splayed sutures (13 percent)",
"     </li>",
"     <li>",
"      Seizures (10 percent)",
"     </li>",
"     <li>",
"      Papilledema (10 percent)",
"     </li>",
"     <li>",
"      Headache (10 percent)",
"     </li>",
"     <li>",
"      Unspecified focal neurologic signs (10 percent)",
"     </li>",
"     <li>",
"      Unspecified symptoms and signs of ICP (9 percent)",
"     </li>",
"     <li>",
"      Focal motor weakness (7 percent)",
"     </li>",
"     <li>",
"      Head tilt (7 percent)",
"     </li>",
"     <li>",
"      Altered level of consciousness (7 percent)",
"     </li>",
"     <li>",
"      Squint (6 percent)",
"     </li>",
"     <li>",
"      Abnormal eye movements (6 percent)",
"     </li>",
"     <li>",
"      Hemiplegia (5 percent)",
"     </li>",
"     <li>",
"      Developmental delay (5 percent)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Tumor location",
"    </span>",
"    &nbsp;&mdash;&nbsp;The site of CNS tumors has a major impact on the presenting signs and symptoms. They include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Localizing symptoms, (eg, abnormal gait and coordination, cranial nerve palsies, and impaired vision). (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Localizing symptoms'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Nonspecific findings, which are generally due to increased ICP (eg, headache, nausea and vomiting, and papilledema)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Major symptoms based upon the tumor location include the following (",
"    <a class=\"graphic graphic_table graphicRef51623 \" href=\"UTD.htm?22/33/23067\">",
"     table 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef55690 \" href=\"UTD.htm?22/52/23370\">",
"     figure 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?12/56/13192/abstract/3\">",
"     3",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Posterior fossa tumors &mdash; Nausea and vomiting, headache, abnormal gait, and coordination",
"     </li>",
"     <li>",
"      Brainstem tumors &mdash; Abnormal gait and coordination, and cranial nerve palsies",
"     </li>",
"     <li>",
"      Spinal cord tumors &mdash; Back pain",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      weakness and abnormal gait",
"     </li>",
"     <li>",
"      Supratentorial and central tumors &mdash; Symptoms that are generally nonspecific, the most common complaint being headache.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Localizing symptoms",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following are the most common localizing symptoms of CNS tumors (",
"    <a class=\"graphic graphic_table graphicRef51623 \" href=\"UTD.htm?22/33/23067\">",
"     table 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Ataxia and difficulty with coordination are frequently present in children with posterior fossa lesions. Initial cerebellar dysfunction may be insidious with clumsiness, worsening handwriting, changes in speech, or difficulty in motor skills, such as running or hopping.",
"     </li>",
"     <li>",
"      Cranial neuropathies, such as diplopia, inability to adduct the eye during attempted lateral gaze, facial palsy, drooling, and difficulties with swallowing suggest underlying brainstem pathology.",
"     </li>",
"     <li>",
"      Impaired vision may be due to cranial neuropathy (eg, diplopia) from a brainstem lesion, increased ICP leading to papilledema, or a lesion along the optic pathway that courses from the occipital pole of the cerebral cortex through the optic chiasm to the retina.",
"      <br/>",
"      <br/>",
"      Chiasmatic tumors often present with a complex visual field loss and decrement in visual acuity. Lesions that are located more posteriorly in the optic tract demonstrate some degree of hemianopsia.",
"     </li>",
"     <li>",
"      Endocrine abnormalities (eg, growth impairment, diabetes insipidus, precocious puberty, and obesity) may be present at the time of diagnosis in children with",
"      <span class=\"nowrap\">",
"       chiasmatic/hypothalamic",
"      </span>",
"      lesions such as craniopharyngioma [",
"      <a class=\"abstract\" href=\"UTD.htm?12/56/13192/abstract/4\">",
"       4",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/60/24520?source=see_link&amp;anchor=H4#H4\">",
"       \"Craniopharyngioma\", section on 'Clinical presentation'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Diencephalic syndrome occurs in infants and young children with tumors in the suprasellar or third ventricular region, and is characterized by failure to thrive with severe emaciation but normal linear growth, increased appetite, and hyperactivity [",
"      <a class=\"abstract\" href=\"UTD.htm?12/56/13192/abstract/5-7\">",
"       5-7",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Peripheral or back pain, focal weakness, gait abnormalities, and spinal deformity are the most common presenting symptoms of a spinal cord tumor [",
"      <a class=\"abstract\" href=\"UTD.htm?12/56/13192/abstract/8\">",
"       8",
"      </a>",
"      ]. In a case series of 35 children with spinal tumors, presenting complaints included pain localized to the back, neck, or extremities (n = 20), extremity weakness (n = 16), gait abnormalities (n = 14), and scoliosis (n = 3) [",
"      <a class=\"abstract\" href=\"UTD.htm?12/56/13192/abstract/9\">",
"       9",
"      </a>",
"      ]. Young children may have difficulty localizing back pain and may complain of abdominal pain instead [",
"      <a class=\"abstract\" href=\"UTD.htm?12/56/13192/abstract/8\">",
"       8",
"      </a>",
"      ]. Cervical tumors may present with torticollis which may be misdiagnosed as lymphadenopathy or local trauma, leading to delayed diagnosis [",
"      <a class=\"abstract\" href=\"UTD.htm?12/56/13192/abstract/8\">",
"       8",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Seizures may be a clinical finding, particularly in patients with low-grade supratentorial lesions [",
"      <a class=\"abstract\" href=\"UTD.htm?12/56/13192/abstract/10\">",
"       10",
"      </a>",
"      ]. Seizures may be an isolated finding or accompanied by other localizing signs and symptoms.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Non-localizing symptoms",
"    </span>",
"    &nbsp;&mdash;&nbsp;In children with CNS tumors, non-localizing signs and symptoms of increased intracranial pressure (ICP) include headache, nausea and vomiting, papilledema, declining academic performance, and changes in behavior and personality. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/37/44633?source=see_link\">",
"     \"Elevated intracranial pressure in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Headache",
"    </span>",
"    &nbsp;&mdash;&nbsp;Headache is the most common manifestation of CNS tumors, occurring in about one-third of affected children. It is a less frequent finding in young children who cannot articulate its presence. In the previously mentioned systematic review, headache was reported in only 10 percent of children with CNS tumors who were less than 4 years of age [",
"    <a class=\"abstract\" href=\"UTD.htm?12/56/13192/abstract/3\">",
"     3",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H3\">",
"     'Infants and young children'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Headaches associated with CNS tumors generally are thought to be due to increased ICP. These headaches are classically described as an early morning headache that is often relieved by vomiting. However, many children do not present with these classic symptoms. This was illustrated in a case series of 200 children with CNS tumors that recorded the pattern of headaches in 71 of 112 patients who presented with headaches [",
"    <a class=\"abstract\" href=\"UTD.htm?12/56/13192/abstract/11\">",
"     11",
"    </a>",
"    ]. Headaches were nocturnal or occurred in the early morning in 43 patients, occurred during the daytime or early evening in 15, and were continuous in the remaining 13.",
"   </p>",
"   <p>",
"    Headaches may be either focal or diffuse. Sometimes, a misdiagnosis of migraine or tension headaches has been made prior to the diagnosis of a CNS tumor. However, such children typically have other CNS manifestations with their headaches, and their presence should differentiate headaches associated with increased ICP from other causes. In the above series of 200 children, all patients with headaches had one or more other CNS tumor-associated symptoms that included vomiting, vision impairment, unsteady gait, changes in behavior or school performance, sleep disturbances, and growth impairment [",
"    <a class=\"abstract\" href=\"UTD.htm?12/56/13192/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Children with persistent headaches should be assessed by a thorough history and physical examination for any signs and symptoms suggestive of CNS tumors. A child with a history of headaches accompanied by other signs of increased ICP or localizing neurologic symptoms (",
"    <a class=\"graphic graphic_table graphicRef67480 \" href=\"UTD.htm?22/11/22715\">",
"     table 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef51623 \" href=\"UTD.htm?22/33/23067\">",
"     table 2",
"    </a>",
"    ) should be further evaluated by neuroimaging. (See",
"    <a class=\"local\" href=\"#H13\">",
"     'Diagnosis'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Nausea and vomiting",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nausea and vomiting are nonspecific symptoms of increased ICP and are commonly present in children with CNS tumors, especially posterior fossa tumors [",
"    <a class=\"abstract\" href=\"UTD.htm?12/56/13192/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Papilledema",
"    </span>",
"    &nbsp;&mdash;&nbsp;Papilledema refers to bilateral optic disc swelling that is due to ICP. It occurs when ICP is transmitted to the optic nerve sheath. It is a physical finding in about 10 to 15 percent of children with CNS tumors, and is more frequent in patients with posterior fossa lesions [",
"    <a class=\"abstract\" href=\"UTD.htm?12/56/13192/abstract/3\">",
"     3",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/53/30552?source=see_link\">",
"     \"Overview and differential diagnosis of papilledema\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Macrocephaly",
"    </span>",
"    &nbsp;&mdash;&nbsp;Macrocephaly can be seen at any age but is most commonly seen in younger children and infants [",
"    <a class=\"abstract\" href=\"UTD.htm?12/56/13192/abstract/3,12\">",
"     3,12",
"    </a>",
"    ]. In infants, increased ICP may be a late finding before closure of fontanelles and fusion of sutures that results in a bulging fontanelle",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    splayed sutures, which accommodate an expanding intracranial mass [",
"    <a class=\"abstract\" href=\"UTD.htm?12/56/13192/abstract/11,12\">",
"     11,12",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Other findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;Changes in behavior or personality, and declining school performance are subtle signs of increased ICP in older children. Younger children and infants may present with irritability and failure to achieve developmental milestones [",
"    <a class=\"abstract\" href=\"UTD.htm?12/56/13192/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Congenital CNS tumors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Congenital CNS tumors are rare, representing less than 2 percent of all childhood brain tumors. They are usually diagnosed because of macrocephaly or a tense fontanel noted at birth, as a result of the tumor itself or secondary to hydrocephalus [",
"    <a class=\"abstract\" href=\"UTD.htm?12/56/13192/abstract/13,14\">",
"     13,14",
"    </a>",
"    ]. Hydrocephalus can be due to direct compression and obstruction of the ventricular system or from increased CSF production from choroid plexus tumor [",
"    <a class=\"abstract\" href=\"UTD.htm?12/56/13192/abstract/14\">",
"     14",
"    </a>",
"    ]. Neurological symptoms as initial symptoms are comparatively rare [",
"    <a class=\"abstract\" href=\"UTD.htm?12/56/13192/abstract/14\">",
"     14",
"    </a>",
"    ]. In some cases, antenatal ultrasound detects the lesion prior to delivery [",
"    <a class=\"abstract\" href=\"UTD.htm?12/56/13192/abstract/13\">",
"     13",
"    </a>",
"    ]; fetal MRI has considerably improved the prenatal diagnosis of these lesions, enabling better management planning, including pregnancy and delivery management, postnatal surgery, and adjuvant therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?12/56/13192/abstract/15\">",
"     15",
"    </a>",
"    ]. In about one-third of pregnancies, polyhydramnios secondary to depressed swallowing from hypothalamic dysfunction is the most common feature [",
"    <a class=\"abstract\" href=\"UTD.htm?12/56/13192/abstract/15\">",
"     15",
"    </a>",
"    ]. Caesarean section may be required to prevent dystocia, with the fetus being at significant risk for tumor rupture and exsanguination [",
"    <a class=\"abstract\" href=\"UTD.htm?12/56/13192/abstract/14\">",
"     14",
"    </a>",
"    ]. The outcome is related to the histology, size, and location of the tumor, the condition of the infant at the time of diagnosis, and is generally poor because of tumor size and location [",
"    <a class=\"abstract\" href=\"UTD.htm?12/56/13192/abstract/14,15\">",
"     14,15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of a CNS tumor is based upon identification of the lesion by neuroimaging, either by magnetic resonance imaging (MRI) or computed tomography (CT). Histological examination is required to make a diagnosis of the specific tumor type. (See",
"    <a class=\"local\" href=\"#H17\">",
"     'Histology'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    As childhood brain tumors have a heterogenous presentation dependent on the tumor location, tumor biology, and age of the child, this often leads to a prolonged symptom interval, which is associated with increased morbidity, increased cognitive impairment, and significant psychosocial distress for the patient, his or her family, and the healthcare professionals involved [",
"    <a class=\"abstract\" href=\"UTD.htm?12/56/13192/abstract/16\">",
"     16",
"    </a>",
"    ]. Knowledge of normal developmental milestones is essential in diagnosing brain tumors in infants and young children, as these patients typically present with subtle, non-specific signs such as developmental delay, and can be easily misdiagnosed. In the United Kingdom, a systematic review reported median symptom intervals from time between symptom onset and diagnosis of brain tumors in children, to range between 2.5 and 3.5 months [",
"    <a class=\"abstract\" href=\"UTD.htm?12/56/13192/abstract/16\">",
"     16",
"    </a>",
"    ]. This is up to three times longer than that experienced by children in North America, Poland, Israel and Switzerland [",
"    <a class=\"abstract\" href=\"UTD.htm?12/56/13192/abstract/16\">",
"     16",
"    </a>",
"    ]. Children with brain tumors who experience long symptom interval are more likely than those diagnosed rapidly, to develop irreversible neurological deficits by diagnosis (particularly visual loss and endocrinopathies) and show greater cognitive deficits in later life [",
"    <a class=\"abstract\" href=\"UTD.htm?12/56/13192/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Neuroimaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;The decision of when to obtain imaging studies is based upon the clinical suspicion that the signs and symptoms are due to a brain tumor. In the attempt to overcome the long median symptom interval to the diagnosis of brain tumors in the UK, an evidence-based guideline derived from the previously discussed systematic review has been developed to assist healthcare professionals in the assessment of children suspected of having a brain tumor [",
"    <a class=\"abstract\" href=\"UTD.htm?12/56/13192/abstract/3,16\">",
"     3,16",
"    </a>",
"    ]. These guidelines include the following criteria for CNS imaging:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Persistent headache in the following settings:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Wakes a child from sleep",
"     </li>",
"     <li>",
"      Occurs upon waking",
"     </li>",
"     <li>",
"      In any child less than 4 years of age",
"     </li>",
"     <li>",
"      Associated with disorientation or confusion",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Persistent vomiting upon waking",
"     </li>",
"     <li>",
"      Visual findings including papilledema, optic atrophy, new onset nystagmus, reduced acuity not due to refractive error, visual field reduction, proptosis, and new onset paralytic (non-comitant) squint",
"     </li>",
"     <li>",
"      Motor findings including regression in motor skills, focal motor weakness, abnormal gait",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      coordination, bell&rsquo;s palsy with no improvement over four weeks, and swallowing difficulties without an identifiable local cause",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Although MRI provides superior imaging compared with CT for brain tumors, CT is often the first imaging study performed because of its generally increased availability and shorter required study time [",
"    <a class=\"abstract\" href=\"UTD.htm?12/56/13192/abstract/17\">",
"     17",
"    </a>",
"    ]. Sedation is often not required for CT, as it has a shorter study time compared with MRI, which often requires conscious sedation, particularly for young children and infants. Thus, CT is often the preferred initial study to diagnosis a brain lesion in an emergent situation with a medically unstable child in whom an elevated ICP is suspected. However, it is important to remember that a normal CT study does not completely exclude the possibility of a brain lesion.",
"   </p>",
"   <p>",
"    MRI imaging is the modality of choice with a child suspected to have a primary spinal tumor. MRI of the spine is also the modality of choice in staging tumors that have a predilection for leptomeningeal spread. (See",
"    <a class=\"local\" href=\"#H15\">",
"     'MRI imaging'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The following discussion is a summary of the different neuroimaging modalities used in the diagnosis of CNS tumors. A more in-depth discussion on neuroimaging in the diagnosis of brain tumors is found separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/3/25657?source=see_link&amp;anchor=H14#H14\">",
"     \"Clinical presentation and diagnosis of brain tumors\", section on 'Diagnostic neuroimaging'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     MRI imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;MRI is currently the best neuroimaging modality for brain tumors. Compared with CT, it provides more detailed images of parenchymal lesions, and is more sensitive in detecting lesions within the posterior fossa, subarachnoid spaces, and leptomeninges (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef78521 \" href=\"UTD.htm?30/20/31041\">",
"     image 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef75202 \" href=\"UTD.htm?6/13/6354\">",
"     image 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef65346 \" href=\"UTD.htm?35/48/36610\">",
"     image 3",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef55787 \" href=\"UTD.htm?32/41/33427\">",
"     image 4",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef53610 \" href=\"UTD.htm?30/35/31284\">",
"     image 5",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Gadolinium-enhanced MRI can also provide information that may indicate a specific tumor type. It is the imaging modality of choice for a child with a suspected spinal cord lesion because it is less invasive than CT myelogram and provides superior imaging of soft tissue structures [",
"    <a class=\"abstract\" href=\"UTD.htm?12/56/13192/abstract/8\">",
"     8",
"    </a>",
"    ]. If a spinal cord tumor is suspected, rapid imaging is critical for detection of the lesion prior to spinal cord compression, which may result in permanent neurologic damage [",
"    <a class=\"abstract\" href=\"UTD.htm?12/56/13192/abstract/8,18-21\">",
"     8,18-21",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/19/36152?source=see_link&amp;anchor=H18#H18\">",
"     \"Clinical features and diagnosis of cervical radiculopathy\", section on 'Imaging studies'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    MRI is also used to stage tumors that have a predilection for leptomeningeal spread. In children, these tumors include medulloblastomas, primitive neuroectodermal tumors, atypical teratoid rhabdoid tumors, ependymomas, germinomas, and high grade astrocytomas. MRI of the spine should be obtained prior to lumbar puncture or surgical intervention for optimal staging, in order to avoid confusion resulting from procedural artifact or blood. If preoperative imaging is not possible, the staging MRI of the spine should be obtained at least 14 days after surgery in order to minimize any changes that are related to the surgical procedure.",
"   </p>",
"   <p>",
"    MR spectroscopy, a supplementation to traditional MRI, can differentiate locally infiltrative brain tumors from other intracranial lesions by detecting the presence of specific metabolic signals (eg, N-acetylaspartate, choline, and lactate) that are present in brain tumor tissue. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/3/25657?source=see_link&amp;anchor=H15#H15\">",
"     \"Clinical presentation and diagnosis of brain tumors\", section on 'Magnetic resonance imaging'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/3/25657?source=see_link&amp;anchor=H16#H16\">",
"     \"Clinical presentation and diagnosis of brain tumors\", section on 'Magnetic resonance spectroscopy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Positron emission tomography scans",
"    </span>",
"    &nbsp;&mdash;&nbsp;Positron emission tomography (PET) scans are not routinely used at all centers as part of standard workup for brain tumors, but they can provide useful information to supplement those from MRI scans. PET scans utilize a positron-emitting radionuclide isotope coupled with a sugar (eg, fluorodeoxyglucose) to differentiate malignant lesions with a high metabolic rate from more benign lesions and surrounding tissue with a lower metabolic rate.",
"   </p>",
"   <p>",
"    PET scan is useful in determining the areas of maximum glucose utilization within the tumor, which can guide the neurosurgeon to biopsy the location within the tumor with the most aggressive behavior. It is also used to differentiate recurrent tumor from changes due to radiotherapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Histology",
"    </span>",
"    &nbsp;&mdash;&nbsp;Children in whom neuroimaging confirms the presence of a mass should be referred to a pediatric neurosurgeon for further evaluation, because the next diagnostic step is to obtain tissue to establish the histologic diagnosis, and whenever possible, reduce the tumor burden for most CNS tumors. Post-surgical therapy, which may include radiation",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    chemotherapy, is dependent upon the histological diagnosis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/26/13736?source=see_link\">",
"     \"Overview of the management of central nervous system tumors in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Diagnostic pitfalls",
"    </span>",
"    &nbsp;&mdash;&nbsp;Since many of the signs and symptoms of childhood CNS tumors are nonspecific and heterogeneous, CNS tumors can be misdiagnosed as common childhood conditions, such as viral gastroenteritis (presentation of nausea and vomiting), and tension and migraine headaches. Less common neurological conditions that may mimic the presentation of a brain tumor include brain abscesses, intracranial hemorrhage, non-neoplastic hydrocephalus, arteriovenous malformations, aneurysms, or indolent viral infections.",
"   </p>",
"   <p>",
"    Children with CNS tumors generally present with more than one tumor-associated symptom or sign, which allows CNS tumors to be distinguished clinically from other conditions. For example, as previously discussed, children with headaches associated with CNS tumors typically have other CNS manifestations, including vomiting, vision impairment, unsteady gait, changes in behavior or school performance, sleep disturbances, and growth impairment [",
"    <a class=\"abstract\" href=\"UTD.htm?12/56/13192/abstract/11\">",
"     11",
"    </a>",
"    ]. However, neuroimaging is needed to definitely differentiate CNS tumors from other diagnoses, and should be performed in any child suspected of having a CNS lesion. (See",
"    <a class=\"local\" href=\"#H7\">",
"     'Headache'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The presenting signs and symptoms of childhood central nervous system (CNS) tumors vary with the child's age and tumor location, and are frequently subtle and nonspecific (",
"      <a class=\"graphic graphic_table graphicRef67480 \" href=\"UTD.htm?22/11/22715\">",
"       table 1",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef51623 \" href=\"UTD.htm?22/33/23067\">",
"       table 2",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      CNS tumors produce symptoms and signs by local invasion, compression of adjacent structures, and increased intracranial pressure (ICP) by either a mass effect, which compresses normal CNS structures, or by causing obstruction of cerebrospinal fluid (CSF) flow, resulting in hydrocephalus. Clinical manifestations include nonspecific findings, which are generally due to increased ICP (eg, headache, nausea, and vomiting, papilledema) and localizing symptoms (eg, abnormal gait and coordination, cranial nerve palsies, and impaired vision). (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Non-localizing symptoms'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H5\">",
"       'Localizing symptoms'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis of a CNS tumor is based upon identification of the lesion by neuroimaging, either by magnetic resonance imaging (MRI) or computed tomography (CT). The decision to perform neuroimaging is based on the clinical suspicion that the presenting signs and symptoms are due to a brain tumor. Although MRI provides superior imaging compared with CT for brain tumors, CT is often the first imaging study performed because of its generally increased availability and shorter study time required. CT, unlike MRI, also does not usually require sedation in infants and younger children. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Neuroimaging'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      MRI imaging is the diagnostic modality of choice in a child suspected of having a spinal tumor. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'MRI imaging'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Children in whom neuroimaging confirms the presence of a mass should be referred to a pediatric neurosurgeon for further evaluation, because obtaining tissue to establish the histologic diagnosis is the next diagnostic step for most childhood CNS tumors. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Diagnosis'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?13/26/13736?source=see_link\">",
"       \"Overview of the management of central nervous system tumors in children\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Because the clinical presentations of childhood CNS tumors can be nonspecific and heterogeneous, CNS tumors can often be initially misdiagnosed. Knowledge of normal developmental milestones is essential in diagnosing brain tumors in infants and young children, as these patients typically present with subtle, non-specific signs such as developmental delay, and can be easily misdiagnosed. Conditions that may mimic CNS tumors include common childhood disorders, such as viral gastroenteritis, and migraine and tension headache, and less commonly, other intracranial space-occupying lesions. Children with CNS tumors often present with more than one tumor-associated symptom or sign, which allows CNS tumors to be distinguished clinically from other conditions. However, neuroimaging is needed to definitively differentiate CNS tumors from other diagnoses and should be performed in any child suspected of having a CNS lesion. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Differential diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/56/13192/abstract/1\">",
"      Linabery AM, Ross JA. Trends in childhood cancer incidence in the U.S. (1992-2004). Cancer 2008; 112:416.",
"     </a>",
"    </li>",
"    <li>",
"     Homer MJ, Ries, LAG, Krapcho, M, et al (eds). SEER Cancer Statistis Review, 1975-2006 file://seer.cancer.gov/csr/1975_2006/ (Accessed on May 20, 2008).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/56/13192/abstract/3\">",
"      Wilne S, Collier J, Kennedy C, et al. Presentation of childhood CNS tumours: a systematic review and meta-analysis. Lancet Oncol 2007; 8:685.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/56/13192/abstract/4\">",
"      Taylor M, Couto-Silva AC, Adan L, et al. Hypothalamic-pituitary lesions in pediatric patients: endocrine symptoms often precede neuro-ophthalmic presenting symptoms. J Pediatr 2012; 161:855.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/56/13192/abstract/5\">",
"      Gropman AL, Packer RJ, Nicholson HS, et al. Treatment of diencephalic syndrome with chemotherapy: growth, tumor response, and long term control. Cancer 1998; 83:166.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/56/13192/abstract/6\">",
"      Pillai MG, Unnikrishnan AG, Nair V, et al. Diencephalic cachexia: a rare cause for failure to thrive. J Pediatr 2005; 147:713.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/56/13192/abstract/7\">",
"      Fleischman A, Brue C, Poussaint TY, et al. Diencephalic syndrome: a cause of failure to thrive and a model of partial growth hormone resistance. Pediatrics 2005; 115:e742.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/56/13192/abstract/8\">",
"      Wilne S, Walker D. Spine and spinal cord tumours in children: a diagnostic and therapeutic challenge to healthcare systems. Arch Dis Child Educ Pract Ed 2010; 95:47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/56/13192/abstract/9\">",
"      Wilson PE, Oleszek JL, Clayton GH. Pediatric spinal cord tumors and masses. J Spinal Cord Med 2007; 30 Suppl 1:S15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/56/13192/abstract/10\">",
"      Fattal-Valevski A, Nissan N, Kramer U, Constantini S. Seizures as the clinical presenting symptom in children with brain tumors. J Child Neurol 2013; 28:292.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/56/13192/abstract/11\">",
"      Wilne SH, Ferris RC, Nathwani A, Kennedy CR. The presenting features of brain tumours: a review of 200 cases. Arch Dis Child 2006; 91:502.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/56/13192/abstract/12\">",
"      Pollack IF. Pediatric brain tumors. Semin Surg Oncol 1999; 16:73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/56/13192/abstract/13\">",
"      Lasky JL, Choi EJ, Johnston S, et al. Congenital brain tumors: case series and review of the literature. J Pediatr Hematol Oncol 2008; 30:326.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/56/13192/abstract/14\">",
"      Isaacs H Jr. I. Perinatal brain tumors: a review of 250 cases. Pediatr Neurol 2002; 27:249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/56/13192/abstract/15\">",
"      Severino M, Schwartz ES, Thurnher MM, et al. Congenital tumors of the central nervous system. Neuroradiology 2010; 52:531.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/56/13192/abstract/16\">",
"      Wilne S, Koller K, Collier J, et al. The diagnosis of brain tumours in children: a guideline to assist healthcare professionals in the assessment of children who may have a brain tumour. Arch Dis Child 2010; 95:534.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/56/13192/abstract/17\">",
"      Matthews PM, Wylezinska M, Cadoux-Hudson T. Novel approaches to imaging brain tumors. Hematol Oncol Clin North Am 2001; 15:609.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/56/13192/abstract/18\">",
"      Houten JK, Babu RP, Miller DC. Thoracic paraganglioma presenting with spinal cord compression and metastases. J Spinal Disord Tech 2002; 15:319.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/56/13192/abstract/19\">",
"      Houten JK, Weiner HL. Pediatric intramedullary spinal cord tumors: special considerations. J Neurooncol 2000; 47:225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/56/13192/abstract/20\">",
"      Merchant TE, Kiehna EN, Thompson SJ, et al. Pediatric low-grade and ependymal spinal cord tumors. Pediatr Neurosurg 2000; 32:30.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/56/13192/abstract/21\">",
"      Mehlman CT, Crawford AH, McMath JA. Pediatric vertebral and spinal cord tumors: a retrospective study of musculoskeletal aspects of presentation, treatment, and complications. Orthopedics 1999; 22:49.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6250 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-58.240.98.179-F8E45503D2-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_56_13192=[""].join("\n");
var outline_f12_56_13192=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H20\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Infants and young children",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Tumor location",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Localizing symptoms",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Non-localizing symptoms",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Headache",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Nausea and vomiting",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Papilledema",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Macrocephaly",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Other findings",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Congenital CNS tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Neuroimaging",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - MRI imaging",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Positron emission tomography scans",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Histology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Diagnostic pitfalls",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/6250\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/6250|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?30/20/31041\" title=\"diagnostic image 1\">",
"      Pilocytic astrocytoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?6/13/6354\" title=\"diagnostic image 2\">",
"      MRI pontine glioma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?35/48/36610\" title=\"diagnostic image 3\">",
"      MRI glioblastoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?32/41/33427\" title=\"diagnostic image 4\">",
"      Imaging medulloblastoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?30/35/31284\" title=\"diagnostic image 5\">",
"      MRI ependymoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/6250|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?22/52/23370\" title=\"figure 1\">",
"      Child CNS tumor site sympt",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/6250|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?22/11/22715\" title=\"table 1\">",
"      Sx CNS tumor elev ICP child",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?22/33/23067\" title=\"table 2\">",
"      Local sx CNS tumor child",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/19/36152?source=related_link\">",
"      Clinical features and diagnosis of cervical radiculopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/60/35784?source=related_link\">",
"      Clinical manifestations and initial surgical approach to patients with malignant gliomas",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/3/25657?source=related_link\">",
"      Clinical presentation and diagnosis of brain tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/60/24520?source=related_link\">",
"      Craniopharyngioma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/1/2071?source=related_link\">",
"      Diagnosis and classification of low-grade gliomas",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/37/44633?source=related_link\">",
"      Elevated intracranial pressure in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/51/15161?source=related_link\">",
"      Ependymoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/21/38230?source=related_link\">",
"      Epidemiology of central nervous system tumors in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/40/40585?source=related_link\">",
"      Focal brainstem glioma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/23/41332?source=related_link\">",
"      Histopathology and molecular pathogenesis of medulloblastoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/1/28694?source=related_link\">",
"      Intradural nerve sheath tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/60/25540?source=related_link\">",
"      Meningioma: Clinical presentation and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/53/30552?source=related_link\">",
"      Overview and differential diagnosis of papilledema",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/26/13736?source=related_link\">",
"      Overview of the management of central nervous system tumors in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/25/30105?source=related_link\">",
"      Pediatric intracranial germ cell tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/63/7161?source=related_link\">",
"      Spinal cord tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/38/34410?source=related_link\">",
"      Tuberous sclerosis complex: Genetics, clinical features, and diagnosis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f12_56_13193="Citalopram: Drug information";
var content_f12_56_13193=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"0\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Citalopram: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?11/49/12054?source=see_link\">",
"    see \"Citalopram: Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"UTD.htm?37/16/38152?source=see_link\">",
"    see \"Citalopram: Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"block black-box-warn drugH1Div\" id=\"F5708670\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     ALERT: U.S. Boxed Warning",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     The FDA-approved labeling includes a boxed warning. See Warnings/Precautions section for a concise summary of this information.  For verbatim wording of the boxed warning, consult the product labeling or",
"     <a href=\"file://www.fda.gov\" target=\"_blank\">",
"      www.fda.gov",
"     </a>",
"     .",
"    </p>",
"   </div>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F151983\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      CeleXA&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F151984\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Apo-Citalopram&reg;;",
"     </li>",
"     <li>",
"      Auro-Citalopram;",
"     </li>",
"     <li>",
"      Ava-Citalopram;",
"     </li>",
"     <li>",
"      Celexa&reg;;",
"     </li>",
"     <li>",
"      Citalopram-Odan;",
"     </li>",
"     <li>",
"      CO Citalopram;",
"     </li>",
"     <li>",
"      CTP 30;",
"     </li>",
"     <li>",
"      Dom-Citalopram;",
"     </li>",
"     <li>",
"      JAMP-Citalopram;",
"     </li>",
"     <li>",
"      Manda-Citalopram;",
"     </li>",
"     <li>",
"      Mint-Citalopram;",
"     </li>",
"     <li>",
"      Mylan-Citalopram;",
"     </li>",
"     <li>",
"      PHL-Citalopram;",
"     </li>",
"     <li>",
"      PMS-Citalopram;",
"     </li>",
"     <li>",
"      Q-Citalopram;",
"     </li>",
"     <li>",
"      RAN&trade;-Citalo;",
"     </li>",
"     <li>",
"      ratio-Citalopram;",
"     </li>",
"     <li>",
"      Riva-Citalopram;",
"     </li>",
"     <li>",
"      Sandoz-Citalopram;",
"     </li>",
"     <li>",
"      Septa-Citalopram;",
"     </li>",
"     <li>",
"      Teva-Citalopram",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F152026\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Antidepressant, Selective Serotonin Reuptake Inhibitor",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F151988\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;margin-left:0em;text-align:justify;display:inline\">",
"     <b>",
"      Depression:",
"     </b>",
"     Adults &lt;60 years: Oral: Initial: 20 mg once daily; increase the dose by 20 mg at an interval of &ge;1 week to a maximum dose of 40 mg daily.",
"     <b>",
"      Note:",
"     </b>",
"     Doses &gt;40 mg daily are not recommended due to the risk of QT prolongation; additional efficacy with doses &gt;40 mg daily has not been demonstrated in clinical trials.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <i>",
"      Poor metabolizers of CYP2C19 or concurrent use of moderate-to-strong CYP2C19 inhibitors (eg, cimetidine, omeprazole):",
"     </i>",
"     Maximum dose: 20 mg daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     <b>",
"      MAO inhibitor recommendations:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <i>",
"      Switching to or from an MAO inhibitor intended to treat psychiatric disorders:",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Allow 14 days to elapse between discontinuing an MAO inhibitor intended to treat psychiatric disorders and initiation of citalopram.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Allow 14 days to elapse between discontinuing citalopram and initiation of an MAO inhibitor intended to treat psychiatric disorders.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <i>",
"      Use with other MAO inhibitors (linezolid or I.V. methylene blue):",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Do not initiate citalopram in patients receiving linezolid or I.V. methylene blue; consider other interventions for psychiatric condition.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     If urgent treatment with linezolid or I.V. methylene blue is required in a patient already receiving citalopram and potential benefits outweigh potential risks, discontinue citalopram promptly and administer linezolid or I.V. methylene blue. Monitor for serotonin syndrome for 2 weeks or until 24 hours after the last dose of linezolid or I.V. methylene blue, whichever comes first. May resume citalopram 24 hours after the last dose of linezolid or I.V. methylene blue.",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F152006\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?37/16/38152?source=see_link\">",
"      see \"Citalopram: Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Obsessive-compulsive disorder (unlabeled use):",
"     </b>",
"     Children and Adolescents: Oral: 10-40 mg/day (Mukaddes, 2003; Thomsen, 1997; Thomsen, 2001)",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F151989\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     <b>",
"      Depression:",
"     </b>",
"     Elderly &ge;60 years: Oral: Initial: 20 mg once daily; maximum dose in adults &ge;60 years: 20 mg daily due to increased exposure and the risk of QT prolongation.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F151990\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     Mild-to-moderate impairment: No dosage adjustment necessary.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     Severe impairment: Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;20 mL/minute: No dosage adjustment provided in manufacturer's labeling (has not been studied); use caution.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F151991\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Initial: 20 mg once daily; maximum recommended dose: 20 mg daily due to decreased clearance and the risk of QT prolongation",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F151959\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Solution, oral: 10 mg/5 mL (240 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral: 10 mg, 20 mg, 40 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     CeleXA&reg;: 10 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     CeleXA&reg;: 20 mg, 40 mg [scored]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F151943\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block meg drugH1Div\" id=\"F7874419\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Guide",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     An FDA-approved patient medication guide, which is available with the product information and at",
"     <a href=\"file://www.fda.gov/downloads/Drugs/DrugSafety/ucm088568.pdf\" target=\"_blank\">",
"      file://www.fda.gov/downloads/Drugs/DrugSafety/ucm088568.pdf",
"     </a>",
"     , must be dispensed with this medication.",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F9460494\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     May be administered without regard to food.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F151962\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of depression",
"    </p>",
"   </div>",
"   <div class=\"block usu drugH1Div\" id=\"F152022\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use - Unlabeled",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Obsessive-compulsive disorder (OCD)",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F152036\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       CeleXA&reg; may be confused with CeleBREX&reg;, Cerebyx&reg;, Ranexa&trade;, ZyPREXA&reg;",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      BEERS Criteria medication:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       This drug may be potentially inappropriate for use in geriatric patients (Quality of evidence - moderate; Strength of recommendation - strong).",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F152024\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &gt;10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Somnolence (18%; dose related), insomnia (15%; dose related)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Nausea (21%), xerostomia (20%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Miscellaneous: Diaphoresis (11%; dose related)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     1% to 10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cardiovascular: QT prolongation (2%), hypotension (&ge;1%), orthostatic hypotension (&ge;1%), tachycardia (&ge;1%), bradycardia (1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Fatigue (5%; dose related), anxiety (4%), agitation (3%), fever (2%), yawning (2%; dose related), amnesia (&ge;1%), apathy (&ge;1%), concentration impaired (&ge;1%), confusion (&ge;1%), depression (&ge;1%), migraine (&ge;1%), suicide attempt (&ge;1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dermatologic: Rash (&ge;1%), pruritus (&ge;1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Libido decreased (1% to 4%), dysmenorrhea (3%), amenorrhea (&ge;1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Diarrhea (8%), dyspepsia (5%), anorexia (4%), vomiting (4%), abdominal pain (3%), appetite increased (&ge;1%), flatulence (&ge;1%), salivation increased (&ge;1%), taste perversion (&ge;1%), weight gain/loss (&ge;1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Genitourinary: Ejaculation disorder (6%), impotence (3%; dose related), polyuria (&ge;1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Tremor (8%), arthralgia (2%), myalgia (2%), paresthesia (&ge;1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Ocular: Abnormal accommodation (&ge;1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Respiratory: Rhinitis (5%), upper respiratory tract infection (5%), sinusitis (3%), cough (&ge;1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &lt;1% (Limited to important or life threatening): Allergic reaction, alopecia, anaphylaxis, anemia, angina pectoris, angioedema, arthritis, asthma, atrial fibrillation, bronchitis, bundle branch block, bursitis, cardiac arrest, cardiac failure, cataracts, catatonia, cerebrovascular accident, cholelithiasis, delirium, delusions, dependence, depersonalization, diplopia, diverticulitis, duodenal ulcer, eczema, epidermal necrolysis, erythema multiforme, extrapyramidal symptoms, extrasystoles, galactorrhea, gastric ulcer, gastrointestinal hemorrhage, glaucoma, granulocytopenia, gynecomastia, hallucinations, hemolytic anemia, hepatic necrosis, hepatitis, hyperpigmentation, hypertension, hypertrichosis, hypoglycemia, hypokalemia, hyponatremia, hypothyroidism, leukocytosis, leukopenia, lymphadenopathy, lymphocytosis, lymphopenia, muscle weakness, myocardial infarction, myocardial ischemia, neuroleptic malignant syndrome, obesity, osteoporosis, pancreatitis, phlebitis, photosensitivity, pneumonia, priapism, prolactinemia, prothrombin decreased, psoriasis, psychosis, ptosis, pulmonary embolism, renal calculi, renal failure, rhabdomyolysis, seizures, serotonin syndrome, SIADH, spontaneous abortion, syncope, thrombocytopenia, thrombosis, torsade de pointes, transient ischemic attack, urinary incontinence, urinary retention, vaginal bleeding, ventricular arrhythmia, withdrawal syndrome",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F151965\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to citalopram or any component of the formulation; use of MAO inhibitors intended to treat psychiatric disorders (concurrently or within 14 days of discontinuing either citalopram or the MAO inhibitor); initiation of citalopram in a patient receiving linezolid or intravenous methylene blue; concomitant use with pimozide",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F151947\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Major psychiatric warnings:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Suicidal thinking/behavior:",
"     <b>",
"      [U.S. Boxed Warning]: Antidepressants increase the risk of suicidal thinking and behavior in children, adolescents, and young adults (18-24 years of age) with major depressive disorder (MDD) and other psychiatric disorders;",
"     </b>",
"     consider risk prior to prescribing. Short-term studies did not show an increased risk in patients &gt;24 years of age and showed a decreased risk in patients &ge;65 years. Closely monitor patients for clinical worsening, suicidality, or unusual changes in behavior, particularly during the initial 1-2 months of therapy or during periods of dosage adjustments (increases or decreases); the patient&rsquo;s family or caregiver should be instructed to closely observe the patient and communicate condition with healthcare provider. A medication guide concerning the use of antidepressants should be dispensed with each prescription.",
"     <b>",
"      Citalopram is not FDA approved for use in children.",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; The possibility of a suicide attempt is inherent in major depression and may persist until remission occurs. Patients treated with antidepressants should be observed for clinical worsening and suicidality, especially during the initial few months of a course of drug therapy, or at times of dose changes, either increases or decreases. Worsening depression and severe abrupt suicidality that are not part of the presenting symptoms may require discontinuation or modification of drug therapy. Use caution in high-risk patients during initiation of therapy.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Prescriptions should be written for the smallest quantity consistent with good patient care. The patient's family or caregiver should be alerted to monitor patients for the emergence of suicidality and associated behaviors such as anxiety, agitation, panic attacks, insomnia, irritability, hostility, impulsivity, akathisia, hypomania, and mania; patients should be instructed to notify their healthcare provider if any of these symptoms or worsening depression or psychosis occur.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Bleeding risk: May impair platelet aggregation resulting in increased risk of bleeding events, particularly if used concomitantly with aspirin, NSAIDs, warfarin, or other anticoagulants. Bleeding (including GI bleeding) related to SSRI or SNRI use has been reported to range from relatively minor bruising and epistaxis to life-threatening hemorrhage.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; CNS depression: Has a low potential to impair cognitive or motor performance; caution operating hazardous machinery or driving.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; QT prolongation: Causes dose-dependent QT",
"     <sub>",
"      c",
"     </sub>",
"     prolongation; torsade de pointes, ventricular tachycardia, and sudden death have been reported. Due to this risk, doses &gt;40 mg/day are not recommended. Additionally, the maximum daily dose should not exceed 20 mg/day in certain populations (eg, CYP2C19 poor metabolizers, patients with hepatic impairment, elderly patients). Use is not recommended in patients with congenital long QT syndrome, bradycardia, recent MI, uncompensated heart failure, hypokalemia, and/or hypomagnesemia, or patients receiving concomitant medications which prolong the QT interval; if use is essential and cannot be avoided in these patients, ECG monitoring is recommended. Discontinue therapy in any patient with persistent QT",
"     <sub>",
"      c",
"     </sub>",
"     measurements &gt;500 msec. Serum electrolytes, particularly potassium and magnesium, should be monitored prior to initiation and periodically during therapy in any patient at increased risk for significant electrolyte disturbances; hypokalemia and/or hypomagnesemia should be corrected prior to use.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Serotonin syndrome: Potentially life-threatening serotonin syndrome (SS) has occurred with serotonergic agents (eg, SSRIs, SNRIs), particularly when used in combination with other serotonergic agents (eg, triptans, TCAs, fentanyl, lithium, tramadol, buspirone, St John&rsquo;s wort, tryptophan) or agents that impair metabolism of serotonin (eg, MOA inhibitors intended to treat psychiatric disorders, other MAO inhibitors [ie, linezolid and intravenous methylene blue]). Monitor patients closely for signs of SS such as mental status changes (eg, agitation, hallucinations, delirium, coma); autonomic instability (eg, tachycardia, labile blood pressure, diaphoresis); neuromuscular changes (eg, tremor, rigidity, myoclonus); GI symptoms (eg, nausea, vomiting, diarrhea); and/or seizures. Discontinue treatment (and any concomitant serotonergic agent) immediately if signs/symptoms arise.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Sexual dysfunction: May cause or exacerbate sexual dysfunction.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; SIADH and hyponatremia: SSRIs and SNRIs have been associated with the development of SIADH; hyponatremia has been reported rarely (including severe cases with serum sodium &lt;110 mmol/L), predominately in the elderly; reversible with discontinuation of treatment. Volume depletion and/or concurrent use of diuretics likely increases risk.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hepatic impairment: Use with caution in patients with hepatic impairment; clearance is decreased and plasma concentrations are increased; a maximum of 20 mg/day is recommended in any patient with hepatic impairment due to the risk of QT prolongation.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Mania/hypomania: May worsen psychosis in some patients or precipitate a shift to mania or hypomania in patients with bipolar disorder. Monotherapy in patients with bipolar disorder should be avoided. Patients presenting with depressive symptoms should be screened for bipolar disorder.",
"     <b>",
"      Citalopram is not FDA approved for the treatment of bipolar depression.",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Renal impairment: Use with caution in patients with severe renal impairment (pharmacokinetic information is not available). Clearance is decreased in patients with mild-to-moderate renal impairment, although no dosage adjustment is necessary.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Seizure disorders: Use with caution in patients with a previous seizure disorder or condition predisposing to seizures such as brain damage or alcoholism.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concurrent drug therapy issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Drug-drug interactions: Potentially significant interactions may exist, requiring dose or frequency adjustment, additional monitoring, and/or selection of alternative therapy. Consult drug interactions database for more detailed information.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; CYP2C19 poor metabolizers: Citalopram exposure and maximum concentrations are increased in CYP2C19 poor metabolizers; a maximum daily dose of 20 mg/day is recommended in these patients.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Elderly: Pharmacokinetics are altered in patients &ge;60 years of age; a lower maximum dose of 20 mg/day is recommended in this population due to the risk of QT prolongation. In addition, may cause or exacerbate syndrome of inappropriate antidiuretic hormone secretion or hyponatremia; use caution and monitor sodium closely with initiation or dosage adjustments in older adults (Beers Criteria).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Pediatrics: Citalopram is not FDA-approved for use in children; however, if used, monitor weight and growth regularly during therapy due to the potential for decreased appetite and weight loss with SSRI use.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Pregnancy: Use caution in pregnant patients; high doses of citalopram have been associated with teratogenicity in animals.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Electroconvulsive therapy (ECT): Use with caution; no clinical studies have assessed the combined use of citalopram and ECT; may increase the risks (eg, cognitive adverse effects) associated with ECT; consider discontinuing, when possible, prior to ECT treatment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Withdrawal syndrome: May cause dysphoric mood, irritability, agitation, dizziness, sensory disturbances (eg, electric shock-like sensations), anxiety, confusion, headache, lethargy, emotional lability, insomnia, hypomania, tinnitus, and seizures. Upon discontinuation of citalopram therapy, gradually taper dose. If intolerable symptoms occur following a decrease in dosage or upon discontinuation of therapy, then resuming the previous dose with a more gradual taper should be considered.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F152019\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Substrate",
"     </b>",
"     of CYP2C19 (major), CYP2D6 (minor), CYP3A4 (major);",
"     <b>",
"      Note:",
"     </b>",
"     Assignment of Major/Minor substrate status based on clinically relevant drug interaction potential;",
"     <b>",
"      Inhibits",
"     </b>",
"     CYP1A2 (weak), CYP2B6 (weak), CYP2C19 (weak), CYP2D6 (weak)",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F151952\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Agents with Antiplatelet Properties (e.g., P2Y12 inhibitors, NSAIDs, SSRIs, etc.): May enhance the anticoagulant effect of other Agents with Antiplatelet Properties.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alcohol (Ethyl): May enhance the adverse/toxic effect of Selective Serotonin Reuptake Inhibitors. Specifically, the risk of psychomotor impairment may be enhanced. Management: Patients receiving selective serotonin reuptake inhibitors should be advised to avoid alcohol.  Monitor for increased psychomotor impairment in patients who consume alcohol during treatment with selective serotonin reuptake inhibitors.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Analgesics (Opioid): May enhance the serotonergic effect of Selective Serotonin Reuptake Inhibitors. This may cause serotonin syndrome.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Anticoagulants: Agents with Antiplatelet Properties may enhance the anticoagulant effect of Anticoagulants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Antidepressants (Serotonin Reuptake Inhibitor/Antagonist): Selective Serotonin Reuptake Inhibitors may enhance the serotonergic effect of Antidepressants (Serotonin Reuptake Inhibitor/Antagonist). This may cause serotonin syndrome.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Antipsychotics: May enhance the serotonergic effect of Serotonin Modulators. This could result in serotonin syndrome.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Aspirin: Selective Serotonin Reuptake Inhibitors may enhance the antiplatelet effect of Aspirin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     BusPIRone: May enhance the serotonergic effect of Selective Serotonin Reuptake Inhibitors. This may cause serotonin syndrome. Selective Serotonin Reuptake Inhibitors may decrease the metabolism of BusPIRone.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CarBAMazepine: May increase the metabolism of Selective Serotonin Reuptake Inhibitors. Specifically those agents metabolized via CYP1A2, 2C, and/or 3A4 isoenzymes. Selective Serotonin Reuptake Inhibitors may decrease the metabolism of CarBAMazepine. Specifically those SSRIs that inhibit CYP3A4 isoenzymes.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cimetidine: May decrease the metabolism of Selective Serotonin Reuptake Inhibitors.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CloZAPine: Selective Serotonin Reuptake Inhibitors may decrease the metabolism of CloZAPine.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CNS Depressants: May enhance the adverse/toxic effect of Selective Serotonin Reuptake Inhibitors. Specifically, the risk of psychomotor impairment may be enhanced.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cobicistat: May increase the serum concentration of Selective Serotonin Reuptake Inhibitors.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Collagenase (Systemic): Agents with Antiplatelet Properties may enhance the adverse/toxic effect of Collagenase (Systemic). Specifically, the risk of injection site bruising and/or bleeding may be increased.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Conivaptan: May increase the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP2C19 Inducers (Strong): May increase the metabolism of CYP2C19 Substrates. Management: Consider an alternative for one of the interacting drugs. Some combinations may be specifically contraindicated. Consult appropriate manufacturer labeling.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP2C19 Inhibitors (Moderate): May increase the serum concentration of Citalopram. Management: Limit citalopram dose to a maximum of 20 mg/day if used with a moderate CYP2C19 inhibitor.  Patients using this combination should be monitored closely for evidence of citalopram toxicity (e.g., serotonin syndrome, QT prolongation, etc.).",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP2C19 Inhibitors (Strong): May increase the serum concentration of Citalopram. Management: Limit citalopram dose to a maximum of 20 mg/day if used with a strong CYP2C19 inhibitor.  Patients using this combination should be monitored closely for evidence of citalopram toxicity (e.g., serotonin syndrome, QT prolongation, etc.).",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Inducers (Strong): May increase the metabolism of CYP3A4 Substrates. Management: Consider an alternative for one of the interacting drugs. Some combinations may be specifically contraindicated. Consult appropriate manufacturer labeling.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Inhibitors (Moderate): May decrease the metabolism of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Inhibitors (Strong): May decrease the metabolism of CYP3A4 Substrates.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cyproheptadine: May diminish the therapeutic effect of Selective Serotonin Reuptake Inhibitors.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dabigatran Etexilate: Agents with Antiplatelet Properties may enhance the anticoagulant effect of Dabigatran Etexilate. Agents with Antiplatelet Properties may increase the serum concentration of Dabigatran Etexilate. This mechanism applies specifically to clopidogrel.  Management: Increase monitoring for signs/symptoms of bleeding. The Canadian product monograph for dabigatran specifically recommends avoiding concomitant use with GIIb/IIIa inhibitors or ticlopidine, or with aspirin used for stroke prevention in atrial fibrillation.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dasatinib: May enhance the anticoagulant effect of Agents with Antiplatelet Properties.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dasatinib: May increase the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Deferasirox: May decrease the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Desmopressin: Selective Serotonin Reuptake Inhibitors may enhance the adverse/toxic effect of Desmopressin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dextromethorphan: Selective Serotonin Reuptake Inhibitors may enhance the serotonergic effect of Dextromethorphan. Selective Serotonin Reuptake Inhibitors may increase the serum concentration of Dextromethorphan.  Management: Avoid the concurrent use of dextromethorphan and SSRIs, particularly fluoxetine and paroxetine, when possible.  The risk for this interaction may persist for several weeks following discontinuation of fluoxetine or paroxetine.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Drotrecogin Alfa (Activated): Agents with Antiplatelet Properties may enhance the adverse/toxic effect of Drotrecogin Alfa (Activated). Bleeding may occur.  Management: When possible, avoid use of drotrecogin within 7 days of use of any IIb/IIIa antagonists, higher dose aspirin (more than 650 mg/day), or use of other antiplatelet agents.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fluconazole: May increase the serum concentration of Citalopram.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Glucosamine: May enhance the antiplatelet effect of Agents with Antiplatelet Properties.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Herbs (Anticoagulant/Antiplatelet Properties) (eg, Alfalfa, Anise, Bilberry): May enhance the adverse/toxic effect of Agents with Antiplatelet Properties. Bleeding may occur.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Highest Risk QTc-Prolonging Agents: May enhance the QTc-prolonging effect of other Highest Risk QTc-Prolonging Agents.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Hypoglycemic Agents: Selective Serotonin Reuptake Inhibitors may enhance the hypoglycemic effect of Hypoglycemic Agents. Selective Serotonin Reuptake Inhibitors may increase the serum concentration of Hypoglycemic Agents.  Management: Consider increased monitoring of glycemic control with concomitant use of a hypoglycemic agent and an SSRI. Dosage adjustments of the hypoglycemic agent may be necessary upon SSRI initiation or discontinuation.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ibritumomab: Agents with Antiplatelet Properties may enhance the adverse/toxic effect of Ibritumomab. Both agents may contribute to impaired platelet function and an increased risk of bleeding.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Iobenguane I 123: Selective Serotonin Reuptake Inhibitors may diminish the therapeutic effect of Iobenguane I 123.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ioflupane I 123: Selective Serotonin Reuptake Inhibitors may diminish the diagnostic effect of Ioflupane I 123.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ivabradine: May enhance the QTc-prolonging effect of Highest Risk QTc-Prolonging Agents.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ivacaftor: May increase the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Linezolid: May enhance the serotonergic effect of Selective Serotonin Reuptake Inhibitors. This could result in serotonin syndrome.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Lithium: May enhance the serotonergic effect of Selective Serotonin Reuptake Inhibitors. This could increase the risk of serotonin toxicity/serotonin syndrome.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Macrolide Antibiotics: May decrease the metabolism of Selective Serotonin Reuptake Inhibitors.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Azithromycin (Systemic); Fidaxomicin; Spiramycin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     MAO Inhibitors: May enhance the serotonergic effect of Selective Serotonin Reuptake Inhibitors. This may cause serotonin syndrome.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methadone: Selective Serotonin Reuptake Inhibitors may decrease the metabolism of Methadone. Fluvoxamine appears to be the only interacting SSRI.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methylene Blue: Selective Serotonin Reuptake Inhibitors may enhance the serotonergic effect of Methylene Blue. This could result in serotonin syndrome.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metoclopramide: May enhance the adverse/toxic effect of Selective Serotonin Reuptake Inhibitors. Management: Seek alternatives to this combination when possible. Monitor patients receiving metoclopramide with selective serotonin reuptake inhibitors for signs of extrapyramidal symptoms, neuroleptic malignant syndrome, and serotonin syndrome.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metoclopramide: Serotonin Modulators may enhance the adverse/toxic effect of Metoclopramide. This may be manifest as symptoms consistent with serotonin syndrome or neuroleptic malignant syndrome.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metyrosine: May enhance the adverse/toxic effect of Selective Serotonin Reuptake Inhibitors.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mexiletine: Selective Serotonin Reuptake Inhibitors may decrease the metabolism of Mexiletine.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mifepristone: May enhance the QTc-prolonging effect of Highest Risk QTc-Prolonging Agents.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Moderate Risk QTc-Prolonging Agents: May enhance the QTc-prolonging effect of Highest Risk QTc-Prolonging Agents.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Multivitamins/Minerals (with ADEK, Folate, Iron): May enhance the antiplatelet effect of Agents with Antiplatelet Properties.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     NSAID (COX-2 Inhibitor): Selective Serotonin Reuptake Inhibitors may enhance the antiplatelet effect of NSAID (COX-2 Inhibitor). NSAID (COX-2 Inhibitor) may diminish the therapeutic effect of Selective Serotonin Reuptake Inhibitors.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     NSAID (Nonselective): Selective Serotonin Reuptake Inhibitors may enhance the antiplatelet effect of NSAID (Nonselective). NSAID (Nonselective) may diminish the therapeutic effect of Selective Serotonin Reuptake Inhibitors.  Management: Consider using alternative analgesics, when appropriate, and/or addition of an gastroprotective agent.  Monitor patients closely for signs/symptoms of bleeding, and for evidence of diminished SSRI effectiveness with concurrent use.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Omega-3 Fatty Acids: May enhance the antiplatelet effect of Agents with Antiplatelet Properties.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Peginterferon Alfa-2b: May decrease the serum concentration of CYP2D6 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pentosan Polysulfate Sodium: May enhance the adverse/toxic effect of Agents with Antiplatelet Properties. Specifically, the risk of bleeding may be increased by concurrent use of these agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pentoxifylline: May enhance the antiplatelet effect of Agents with Antiplatelet Properties.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pimozide: Selective Serotonin Reuptake Inhibitors may enhance the adverse/toxic effect of Pimozide.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Prostacyclin Analogues: May enhance the antiplatelet effect of Agents with Antiplatelet Properties.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     QTc-Prolonging Agents (Indeterminate Risk and Risk Modifying): May enhance the QTc-prolonging effect of Highest Risk QTc-Prolonging Agents. Management: Avoid such combinations when possible.  Use should be accompanied by close monitoring for evidence of QT prolongation or other alterations of cardiac rhythm.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     RisperiDONE: Selective Serotonin Reuptake Inhibitors may decrease the metabolism of RisperiDONE.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rivaroxaban: Agents with Antiplatelet Properties may enhance the anticoagulant effect of Rivaroxaban.  Management: Avoid concurrent use of clopidogrel with rivaroxaban unless the anticipated benefits outweigh the risks of bleeding.  Avoid concurrent use of rivaroxaban with other antiplatelet agents whenever possible.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Salicylates: Agents with Antiplatelet Properties may enhance the adverse/toxic effect of Salicylates. Increased risk of bleeding may result.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Serotonin Modulators: May enhance the adverse/toxic effect of other Serotonin Modulators. The development of serotonin syndrome may occur.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Thrombolytic Agents: Agents with Antiplatelet Properties may enhance the anticoagulant effect of Thrombolytic Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tipranavir: May enhance the antiplatelet effect of Agents with Antiplatelet Properties.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tocilizumab: May decrease the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tositumomab and Iodine I 131 Tositumomab: Agents with Antiplatelet Properties may enhance the adverse/toxic effect of Tositumomab and Iodine I 131 Tositumomab. Specifically, the risk of bleeding-related adverse events may be increased.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     TraMADol: Selective Serotonin Reuptake Inhibitors may enhance the neuroexcitatory and/or seizure-potentiating effect of TraMADol. TraMADol may enhance the serotonergic effect of Selective Serotonin Reuptake Inhibitors. This may cause serotonin syndrome.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tricyclic Antidepressants: Selective Serotonin Reuptake Inhibitors may decrease the metabolism of Tricyclic Antidepressants.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tryptophan: May enhance the serotonergic effect of Selective Serotonin Reuptake Inhibitors. This may cause serotonin syndrome.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vitamin E: May enhance the antiplatelet effect of Agents with Antiplatelet Properties.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vitamin K Antagonists (eg, warfarin): Selective Serotonin Reuptake Inhibitors may enhance the anticoagulant effect of Vitamin K Antagonists.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F151979\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Ethanol/Nutrition/Herb Interactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ethanol: May increase CNS depression; monitor for increased effects with coadministration. Caution patients about effects.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Herb/Nutraceutical: Avoid valerian, St John's wort, tryptophan, SAMe, kava kava, and gotu kola (may increase CNS depression).",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F151954\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F151968\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adverse events have been observed in animal reproduction studies. Citalopram and its metabolites cross the human placenta. An increased risk of teratogenic effects, including cardiovascular defects, may be associated with maternal use of citalopram or other SSRIs; however, available information is conflicting. Nonteratogenic effects in the newborn following SSRI/SNRI exposure late in the third trimester include respiratory distress, cyanosis, apnea, seizures, temperature instability, feeding difficulty, vomiting, hypoglycemia, hypo- or hypertonia, hyper-reflexia, jitteriness, irritability, constant crying, and tremor. Symptoms may be due to the toxicity of the SSRIs/SNRIs or a discontinuation syndrome and may be consistent with serotonin syndrome associated with SSRI treatment. Persistent pulmonary hypertension of the newborn (PPHN) has also been reported with SSRI exposure. The long-term effects of",
"     <i>",
"      in utero",
"     </i>",
"     SSRI exposure on infant development and behavior are not known.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Due to pregnancy-induced physiologic changes, women who are pregnant may require adjusted doses of citalopram to achieve euthymia. The ACOG recommends that therapy with SSRIs or SNRIs during pregnancy be individualized; treatment of depression during pregnancy should incorporate the clinical expertise of the mental health clinician, obstetrician, primary healthcare provider, and pediatrician. According to the American Psychiatric Association (APA), the risks of medication treatment should be weighed against other treatment options and untreated depression. For women who discontinue antidepressant medications during pregnancy and who may be at high risk for postpartum depression, the medications can be restarted following delivery. Treatment algorithms have been developed by the ACOG and the APA for the management of depression in women prior to conception and during pregnancy.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F151994\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Enters breast milk/consider risk:benefit",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F151969\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Citalopram and its metabolites are excreted in breast milk. According to the manufacturer, the decision to continue or discontinue breast-feeding during therapy should take into account the risk of exposure to the infant and the benefits of treatment to the mother. Excessive somnolence, decreased feeding, colic, irritability, restlessness, and weight loss have been reported in breast-fed infants. The long-term effects on development and behavior have not been studied; therefore, citalopram should be prescribed to a mother who is breast-feeding only when the benefits outweigh the potential risks. Maternal use of an SSRI during pregnancy may cause delayed milk secretion.",
"    </p>",
"   </div>",
"   <div class=\"block dic drugH1Div\" id=\"F151970\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dietary Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     May be taken without regard to food.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F151967\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Citalopram Hydrobromide Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     10 mg/5 mL (240 mL): $117.50",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (CeleXA Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     10 mg (100): $492.20",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     20 mg (100): $513.01",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     40 mg (100): $535.36",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Citalopram Hydrobromide Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     10 mg (100): $244.50",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     20 mg (100): $255.50",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     40 mg (100): $265.50",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F151956\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     ECG (patients at increased risk for QT-prolonging effects due to certain conditions); electrolytes (potassium and magnesium concentrations [prior to initiation and periodically during therapy in patients at increased risk for electrolyte abnormalities]); signs/symptoms of arrhythmias (eg, dizziness, palpitations, syncope); liver function tests and CBC with continued therapy; monitor patient periodically for symptom resolution; signs/symptoms of serotonin syndrome; mental status for depression, suicidal ideation (especially at the beginning of therapy or when doses are increased or decreased), anxiety, social functioning, mania, panic attacks; akathisia",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F151971\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Arpolax (HK);",
"     </li>",
"     <li>",
"      Celapram (AU, NZ);",
"     </li>",
"     <li>",
"      Celica (AU);",
"     </li>",
"     <li>",
"      Ciazil (AU);",
"     </li>",
"     <li>",
"      Cipram (AE, BF, BH, BJ, CI, CY, EG, ET, GH, GM, GN, GR, HK, ID, IQ, IR, JO, KE, KP, KW, LB, LR, LY, MA, ML, MR, MU, MW, MY, NE, NG, OM, PK, QA, SA, SC, SD, SG, SL, SN, SY, TH, TN, TR, TW, TZ, UG, YE, ZM, ZW);",
"     </li>",
"     <li>",
"      Cipramil (AU, BE, BR, CN, DE, DK, EE, FI, GB, IE, IL, LU, NL, NO, NZ, PE, PL, RU, SE, ZA);",
"     </li>",
"     <li>",
"      Ciram (SG);",
"     </li>",
"     <li>",
"      Cital (MY);",
"     </li>",
"     <li>",
"      Citalobell (AU);",
"     </li>",
"     <li>",
"      Citao (TW);",
"     </li>",
"     <li>",
"      Citazone (CO);",
"     </li>",
"     <li>",
"      Citopam (IN);",
"     </li>",
"     <li>",
"      Citox (MX);",
"     </li>",
"     <li>",
"      Feliz (PH);",
"     </li>",
"     <li>",
"      Humorap (EC, PY);",
"     </li>",
"     <li>",
"      Kitapram (TW);",
"     </li>",
"     <li>",
"      Lupram (PH);",
"     </li>",
"     <li>",
"      Psiconor (UY);",
"     </li>",
"     <li>",
"      Recital (IL);",
"     </li>",
"     <li>",
"      Sepram (FI);",
"     </li>",
"     <li>",
"      Seropram (AT, BG, CH, CZ, ES, FR, GR, HN, HU, IT, MX, VE);",
"     </li>",
"     <li>",
"      Talam (AU);",
"     </li>",
"     <li>",
"      Xylorane (MX);",
"     </li>",
"     <li>",
"      Zalopram (DO);",
"     </li>",
"     <li>",
"      Zentius (AR, CN)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F151946\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     A racemic bicyclic phthalane derivative, citalopram selectively inhibits serotonin reuptake in the presynaptic neurons and has minimal effects on norepinephrine or dopamine. Uptake inhibition of serotonin is primarily due to the",
"     <i>",
"      S",
"     </i>",
"     -enantiomer of citalopram. Displays little to no affinity for serotonin, dopamine, adrenergic, histamine, GABA, or muscarinic receptor subtypes.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F151964\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Onset of action: Depression: The onset of action is 1-4 weeks; however, individual response varies greatly and full response may not be seen until 8-12 weeks after initiation of treatment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: V",
"     <sub>",
"      d",
"     </sub>",
"     : 12 L/kg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding, plasma: ~80%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Extensively hepatic, via CYP3A4 and 2C19 (major pathways), and 2D6 (minor pathway); metabolized to demethylcitalopram (DCT),  didemethylcitalopram (DDCT), citalopram-N-oxide, and a deaminated propionic acid derivative, which are at least eight times less potent than citalopram",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Bioavailability: 80%; tablets and oral solution are bioequivalent",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life elimination: 24-48 hours (average: 35 hours); doubled with hepatic impairment and increased by 30% (following multiple doses) to 50% (following single dose) in elderly patients (&ge;60 years)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak, serum: 1-6 hours, average within 4 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Urine (Citalopram 10% and DCT 5%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Note:",
"     </b>",
"     Clearance was decreased, while half-life was significantly increased in patients with hepatic impairment. Mild-to-moderate renal impairment may reduce clearance (17%) and prolong half-life of citalopram. No pharmacokinetic information is available concerning patients with severe renal impairment. AUC and half-life were significantly increased in elderly patients (&ge;60 years), and in poor CYP2C19 metabolizers, steady state C",
"     <sub>",
"      max",
"     </sub>",
"     and AUC was increased by 68% and 107%, respectively.",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      American College of Obstetricians and Gynecologists, ACOG Practice Bulletin: Clinical Management Guidelines for Obstetricians-Gynecologists No. 92 April 2008 (Replaces Practice Bulletin Number 87, November 2007), &ldquo;Use of Psychiatric Medications During Pregnancy and Lactation,&rdquo;",
"      <i>",
"       Obstet Gynecol",
"      </i>",
"      , 2008, 111(4):1001-20.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?12/56/13193/abstract-text/18378767/pubmed\" id=\"18378767\" target=\"_blank\">",
"        18378767",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      American Geriatrics Society 2012 Beers Criteria Update Expert Panel, \"American Geriatrics Society Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults,\"",
"      <i>",
"       J Am Geriatr Soc",
"      </i>",
"      , 2012, 60(4):616-31.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?12/56/13193/abstract-text/22376048/pubmed\" id=\"22376048\" target=\"_blank\">",
"        22376048",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Bernard L, Stern R, Lew D, et al, &ldquo;Serotonin Syndrome After Concomitant Treatment With Linezolid and Citalopram,&rdquo;",
"      <i>",
"       Clin Infect Dis",
"      </i>",
"      , 2003, 36(9):1197.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?12/56/13193/abstract-text/12715317/pubmed\" id=\"12715317\" target=\"_blank\">",
"        12715317",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Boyer EW and Shannon M, &ldquo;The Serotonin Syndrome,&rdquo;",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 2005, 352:1112-20.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?12/56/13193/abstract-text/15784664/pubmed\" id=\"15784664\" target=\"_blank\">",
"        15784664",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Chambers CD, Hernandez-Diaz S, Van Marter LJ, et al, &ldquo;Selective Serotonin-Reuptake Inhibitors and Risk of Persistent Pulmonary Hypertension of the Newborn,&rdquo;",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 2006, 354(6):579-87.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?12/56/13193/abstract-text/16467545/pubmed\" id=\"16467545\" target=\"_blank\">",
"        16467545",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Dunkley EJ, Isbister GK, Sibbritt D, et al, &ldquo;The Hunter Serotonin Toxicity Criteria: Simple and Accurate Diagnostic Decision Rules for Serotonin Toxicity,&rdquo;",
"      <i>",
"       QJM",
"      </i>",
"      , 2003, 96(9):635-42.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?12/56/13193/abstract-text/12925718/pubmed\" id=\"12925718\" target=\"_blank\">",
"        12925718",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Koran LM, Hanna GL, Hollander E, et al, &ldquo;Practice guidelines for the Treatment of Patients with Obsessive-Compulsive Disorder,\"",
"      <i>",
"       Am J Psychiatry",
"      </i>",
"      , 2007, 164(7 Suppl):5-53. Available at file://psychiatryonline.org/guidelines.aspx.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Mahlberg R, Kunz D, Sasse J, et al, &ldquo;Serotonin Syndrome With Tramadol and Citalopram,&rdquo;",
"      <i>",
"       Am J Psychiatry",
"      </i>",
"      , 2004, 161(6):1129.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?12/56/13193/abstract-text/15169709/pubmed\" id=\"15169709\" target=\"_blank\">",
"        15169709",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Mokhlesi B, Leikin JB, Murray P, et al, &ldquo;Adult Toxicology in Critical Care: Part II: Specific Poisonings,&rdquo;",
"      <i>",
"       Chest",
"      </i>",
"      , 2003, 123(3):897-922.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?12/56/13193/abstract-text/12628894/pubmed\" id=\"12628894\" target=\"_blank\">",
"        12628894",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Mukaddes NM, Abali O, and Kaynak N, \"Citalopram Treatment of Children and Adolescents With Obsessive-Compulsive Disorder: A Preliminary Report,\"",
"      <i>",
"       Psychiatry Clin Neurosci",
"      </i>",
"      , 2003, 57(4):405-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?12/56/13193/abstract-text/12839522/pubmed\" id=\"12839522\" target=\"_blank\">",
"        12839522",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Nelson JC and Devanand DP, \"A Systematic Review and Meta-Analysis of Placebo-Controlled Antidepressant Studies in People With Depression and Dementia,\"",
"      <i>",
"       J Am Geriatr Soc",
"      </i>",
"      , 2011, 59(4):577-85.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?12/56/13193/abstract-text/21453380/pubmed\" id=\"21453380\" target=\"_blank\">",
"        21453380",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Pass SE and Simpson RW, &ldquo;Discontinuation and Reinstitution of Medications During the Perioperative Period,&rdquo;",
"      <i>",
"       Am J Health Syst Pharm",
"      </i>",
"      , 2004, 61(9):899-912.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?12/56/13193/abstract-text/15156966/pubmed\" id=\"15156966\" target=\"_blank\">",
"        15156966",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Stevens DL, &ldquo;Association Between Selective Serotonin-Reuptake Inhibitors, Second-Generation Antipsychotics, and Neuroleptic Malignant Syndrome,&rdquo;",
"      <i>",
"       Ann Pharmacother",
"      </i>",
"      , 2008, 42(9):1290-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?12/56/13193/abstract-text/18628446/pubmed\" id=\"18628446\" target=\"_blank\">",
"        18628446",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Tahir N, &ldquo;Serotonin Syndrome as a Consequence of Drug-Resistant Infections: An Interaction Between Linezolid and Citalopram,",
"      <i>",
"       J Am Med Dir Assoc",
"      </i>",
"      , 2004, 5(2):111-3.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?12/56/13193/abstract-text/14984623/pubmed\" id=\"14984623\" target=\"_blank\">",
"        14984623",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Thomsen PH, &ldquo;Child and Adolescent Obsessive-Compulsive Disorder Treated With Citalopram: Findings From an Open Trial of 23 Cases,&rdquo;",
"      <i>",
"       J Child Adolesc Psychopharmacol",
"      </i>",
"      , 1997, 7(3):157-66.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?12/56/13193/abstract-text/9466233/pubmed\" id=\"9466233\" target=\"_blank\">",
"        9466233",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Thomsen PH, Ebbesen C, and Persson C, \"Long-Term Experience With Citalopram in the Treatment of Adolescent OCD,\"",
"      <i>",
"       J Am Acad Child Adolesc Psychiatry",
"      </i>",
"      , 2001, 40(8):895-902.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?12/56/13193/abstract-text/11501688/pubmed\" id=\"11501688\" target=\"_blank\">",
"        11501688",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Yonkers KA, Wisner KL, Stewart DE, et al, &ldquo;The Management of Depression During Pregnancy: A Report From the American Psychiatric Association and the American College of Obstetricians and Gynecologists,&rdquo;",
"      <i>",
"       Obstet Gynecol",
"      </i>",
"      , 2009, 114(3):703-13.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?12/56/13193/abstract-text/19701065/pubmed\" id=\"19701065\" target=\"_blank\">",
"        19701065",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8874 Version 49.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-194.187.108.93-9EF4B3CCD6-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_56_13193=[""].join("\n");
var outline_f12_56_13193=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5708670\">",
"      ALERT: U.S. Boxed Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F151983\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F151984\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F152026\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F151988\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F152006\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F151989\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F151990\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F151991\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F151959\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F151943\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F7874419\">",
"      Medication Guide",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9460494\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F151962\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F152022\">",
"      Use - Unlabeled",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F152036\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F152024\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F151965\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F151947\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F152019\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F151952\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F151979\">",
"      Ethanol/Nutrition/Herb Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F151954\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F151968\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F151994\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F151969\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F151970\">",
"      Dietary Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F151967\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F151956\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F151971\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F151946\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F151964\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/8874\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/8874|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?11/49/12054?source=related_link\">",
"      Citalopram: Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?37/16/38152?source=related_link\">",
"      Citalopram: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f12_56_13194="Anatomy of the foot";
var content_f12_56_13194=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F58407&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F58407&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 518px\">",
"   <div class=\"ttl\">",
"    Anatomy of the foot",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 498px; height: 717px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_56_13194=[""].join("\n");
var outline_f12_56_13194=null;
var title_f12_56_13195="Paris classification system of superficial lesions";
var content_f12_56_13195=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F50239&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F50239&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Paris classification system of superficial gastrointestinal neoplastic lesions",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Type",
"       </td>",
"       <td class=\"subtitle1\">",
"        Subclasses",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"2\">",
"        <strong>",
"         0-I: Polypoid",
"        </strong>",
"       </td>",
"       <td>",
"        0-Ip: Protruded, pedunculated",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        0-Is: Protruded, sessile",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"3\">",
"        <strong>",
"         0-II: Nonpolypoid",
"        </strong>",
"       </td>",
"       <td>",
"        0-IIa: Slightly elevated",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        0-IIb: Flat",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        0-IIc: Slightly depressed",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td colspan=\"2\">",
"        <strong>",
"         0-III: Excavated",
"        </strong>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     The Paris endoscopic classification of superficial neoplastic lesions: Esophagus, stomach and colon: November 30 to December 1, 2002. Gastrointest Endosc 2003; 58(6 suppl):S3.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_56_13195=[""].join("\n");
var outline_f12_56_13195=null;
var title_f12_56_13196="Inherited disorders associated with pancreatic NETs";
var content_f12_56_13196=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F70019&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F70019&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Inherited disorders associated with pancreatic neuroendocrine tumors",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"4\" width=\"25%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Syndrome",
"       </td>",
"       <td class=\"subtitle1\">",
"        Associated clinical features",
"       </td>",
"       <td class=\"subtitle1\">",
"        Chromosomal location",
"       </td>",
"       <td class=\"subtitle1\">",
"        Pancreatic neuroendocrine tumor type",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td>",
"        MEN1",
"       </td>",
"       <td>",
"        <p class=\"indent1\">",
"         Primary hyperparathyroidism",
"        </p>",
"        <p>",
"         Pituitary tumors",
"        </p>",
"        Less commonly",
"        <br/>",
"        <ul>",
"         <li>",
"          Adrenocortical tumors",
"         </li>",
"         <li>",
"          Carcinoid tumors",
"         </li>",
"         <li>",
"          Nonmedullary thyroid tumors",
"         </li>",
"        </ul>",
"       </td>",
"       <td>",
"        11q13",
"       </td>",
"       <td>",
"        <p>",
"         Nonfunctional",
"        </p>",
"        <p>",
"         Gastrinoma",
"        </p>",
"        <p>",
"         Insulinoma",
"        </p>",
"        Various",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td>",
"        Von Hippel-Lindau disease (VHL)",
"       </td>",
"       <td>",
"        <p>",
"         Pheochromocytoma (often bilateral)",
"        </p>",
"        <p>",
"         Retinal and cerebellar hemangioblastomas",
"        </p>",
"        Renal cell carcinoma",
"       </td>",
"       <td>",
"        3p25-26",
"       </td>",
"       <td>",
"        <p>",
"         Nonfunctional",
"        </p>",
"        Various, including cystic tumors",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td>",
"        Neurofibromatosis 1",
"        <br/>",
"        (von Recklinghausen disease)",
"       </td>",
"       <td>",
"        <p>",
"         Neurofibromas",
"        </p>",
"        <p>",
"         Caf&eacute; au lait spots",
"        </p>",
"        Pheochromocytoma",
"       </td>",
"       <td>",
"        17q11.2",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Tuberous sclerosis",
"       </td>",
"       <td>",
"        <p>",
"         Cardiac rhabdomyomas",
"        </p>",
"        <p>",
"         Renal cysts",
"        </p>",
"        Angiomyolipomas",
"       </td>",
"       <td>",
"        9q33.34 and 16p13.3",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Milan S, Yeo CJ. Neuroendocrine tumors of the pancreas. Curr Opin Oncol 2012; 24:46. Copyright &copy; 2012 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_56_13196=[""].join("\n");
var outline_f12_56_13196=null;
var title_f12_56_13197="Pregnancy rate during first year of contraception";
var content_f12_56_13197=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F70218&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F70218&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Pregnancy rate (percent) during first year of use of contraceptives",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle1\">",
"        Typical use",
"       </td>",
"       <td class=\"subtitle1\">",
"        Correct use",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\" colspan=\"3\">",
"        Condom",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Male",
"       </td>",
"       <td class=\"sublist_other\">",
"        18",
"       </td>",
"       <td class=\"sublist_other\">",
"        2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Female",
"       </td>",
"       <td class=\"sublist_other\">",
"        21",
"       </td>",
"       <td class=\"sublist_other\">",
"        5",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Diaphragm",
"       </td>",
"       <td>",
"        12",
"       </td>",
"       <td>",
"        6",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\" colspan=\"3\">",
"        Sponge",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Previous births",
"       </td>",
"       <td class=\"sublist_other\">",
"        24",
"       </td>",
"       <td class=\"sublist_other\">",
"        20",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        No previous births",
"       </td>",
"       <td class=\"sublist_other\">",
"        12",
"       </td>",
"       <td class=\"sublist_other\">",
"        9",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\" colspan=\"3\">",
"        Fertility awareness-based methods",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Cervical mucus or ovulation",
"       </td>",
"       <td class=\"sublist_other\">",
"        24",
"       </td>",
"       <td class=\"sublist_other\">",
"        3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Symptothermal",
"       </td>",
"       <td class=\"sublist_other\">",
"        24",
"       </td>",
"       <td class=\"sublist_other\">",
"        0.4",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        TwoDay",
"       </td>",
"       <td class=\"sublist_other\">",
"        24",
"       </td>",
"       <td class=\"sublist_other\">",
"        4",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Standard days",
"       </td>",
"       <td class=\"sublist_other\">",
"        24",
"       </td>",
"       <td class=\"sublist_other\">",
"        5",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Withdrawal",
"       </td>",
"       <td>",
"        22",
"       </td>",
"       <td>",
"        4",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Depo-provera (DMPA)&nbsp;injection",
"       </td>",
"       <td>",
"        6",
"       </td>",
"       <td>",
"        &lt;1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\" colspan=\"3\">",
"        Intrauterine device",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Copper T or Mirena",
"       </td>",
"       <td class=\"sublist_other\">",
"        &lt;1",
"       </td>",
"       <td class=\"sublist_other\">",
"        &lt;1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Contraceptive patch",
"       </td>",
"       <td>",
"        9",
"       </td>",
"       <td>",
"        &lt;1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\" colspan=\"3\">",
"        Contraceptive pills",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Progestin only or combination estrogen-progestin",
"       </td>",
"       <td class=\"sublist_other\">",
"        9",
"       </td>",
"       <td class=\"sublist_other\">",
"        &lt;1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Contraceptive vaginal ring",
"       </td>",
"       <td>",
"        9",
"       </td>",
"       <td>",
"        &lt;1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Female sterilization",
"       </td>",
"       <td>",
"        &lt;1",
"       </td>",
"       <td>",
"        &lt;1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Vasectomy",
"       </td>",
"       <td>",
"        &lt;1",
"       </td>",
"       <td>",
"        &lt;1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Etonogestrel implant",
"       </td>",
"       <td>",
"        &lt;1",
"       </td>",
"       <td>",
"        &lt;1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Spermicides",
"       </td>",
"       <td>",
"        28",
"       </td>",
"       <td>",
"        18",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        No method",
"       </td>",
"       <td>",
"        85",
"       </td>",
"       <td>",
"        85",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    Data refer to number of pregnancies per 100 women during first year of use.",
"    <br>",
"     Typical use: refers to failure rates for women and men whose use is not consistent or always correct.",
"     <br>",
"      Correct use: refers to failure rates for those whose use is consistent and always correct.",
"      <div class=\"footnotes\">",
"       * Rate reflects cumulative pregnancy rate in the first&nbsp;six months following birth.",
"      </div>",
"      <div class=\"reference\">",
"       Data adapted from: Contraceptive Technology, 20th edition, 2011 and Trussell J. Contraceptive failure in the United States. Contraception 2011; 83:397.",
"      </div>",
"     </br>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_56_13197=[""].join("\n");
var outline_f12_56_13197=null;
var title_f12_56_13198="CALGB regimen ALL adults";
var content_f12_56_13198=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F67471&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F67471&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Cancer and Leukemia Group B (CALGB) study 9111 chemotherapy regimen for acute lymphoblastic leukemia in adults",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"4\">",
"        Course I: Induction (4 weeks)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"4\">",
"        For patients &lt;60 years old:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Cyclophosphamide",
"       </td>",
"       <td>",
"        IV",
"       </td>",
"       <td>",
"        1200 mg/m",
"        <sup>",
"         2",
"        </sup>",
"       </td>",
"       <td>",
"        Day 1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Daunorubicin",
"       </td>",
"       <td>",
"        IV",
"       </td>",
"       <td>",
"        45 mg/m",
"        <sup>",
"         2",
"        </sup>",
"        /day",
"       </td>",
"       <td>",
"        Days 1-3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Vincristine",
"       </td>",
"       <td>",
"        IV",
"       </td>",
"       <td>",
"        2 mg",
"       </td>",
"       <td>",
"        Days 1, 8, 15, 22",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Prednisone",
"       </td>",
"       <td>",
"        PO",
"       </td>",
"       <td>",
"        60 mg/m",
"        <sup>",
"         2",
"        </sup>",
"        /day",
"       </td>",
"       <td>",
"        Days 1-21",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Asparaginase (E. coli)",
"       </td>",
"       <td>",
"        SC/IM",
"       </td>",
"       <td>",
"        6000 units/m",
"        <sup>",
"         2",
"        </sup>",
"       </td>",
"       <td>",
"        Days 5, 8, 11, 15, 18, 22",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"4\">",
"        For patients &ge;60 years old:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Cyclophosphamide",
"       </td>",
"       <td>",
"        IV",
"       </td>",
"       <td>",
"        800 mg/m",
"        <sup>",
"         2",
"        </sup>",
"       </td>",
"       <td>",
"        Day 1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Daunorubicin",
"       </td>",
"       <td>",
"        IV",
"       </td>",
"       <td>",
"        30 mg/m",
"        <sup>",
"         2",
"        </sup>",
"        /day",
"       </td>",
"       <td>",
"        Days 1-3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Vincristine",
"       </td>",
"       <td>",
"        IV",
"       </td>",
"       <td>",
"        2 mg",
"       </td>",
"       <td>",
"        Days 1, 8, 15, 22",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Prednisone",
"       </td>",
"       <td>",
"        PO",
"       </td>",
"       <td>",
"        60 mg/m",
"        <sup>",
"         2",
"        </sup>",
"        /day",
"       </td>",
"       <td>",
"        Days 1-7",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Asparaginase (E. coli)",
"       </td>",
"       <td>",
"        SC/IM",
"       </td>",
"       <td>",
"        6000 units/m",
"        <sup>",
"         2",
"        </sup>",
"       </td>",
"       <td>",
"        Days 5, 8, 11, 15, 18, 22",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"4\">",
"        All patients receive filgrastim (G-CSF) 5 mcg/kg subcutaneously once per day starting on day 4 and continuing until the ANC is &gt;1000/microL on two consecutive determinations &gt;24 hours apart.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"4\">",
"        Course IIA: Early intensification (4 weeks; repeat once for Course IIB)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Intrathecal methotrexate",
"       </td>",
"       <td>",
"        IT",
"       </td>",
"       <td>",
"        15 mg",
"       </td>",
"       <td>",
"        Day 1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cyclophosphamide",
"       </td>",
"       <td>",
"        IV",
"       </td>",
"       <td>",
"        1000 mg/m",
"        <sup>",
"         2",
"        </sup>",
"       </td>",
"       <td>",
"        Day 1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Mercaptopurine",
"       </td>",
"       <td>",
"        PO",
"       </td>",
"       <td>",
"        60 mg/m",
"        <sup>",
"         2",
"        </sup>",
"        /day",
"       </td>",
"       <td>",
"        Days 1-14",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cytarabine",
"       </td>",
"       <td>",
"        SC",
"       </td>",
"       <td>",
"        75 mg/m",
"        <sup>",
"         2",
"        </sup>",
"        /day",
"       </td>",
"       <td>",
"        Days 1-4, 8-11",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Vincristine",
"       </td>",
"       <td>",
"        IV",
"       </td>",
"       <td>",
"        2 mg",
"       </td>",
"       <td>",
"        Days 15, 22",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Asparaginase (E. coli)",
"       </td>",
"       <td>",
"        SC/IM",
"       </td>",
"       <td>",
"        6000 units/m",
"        <sup>",
"         2",
"        </sup>",
"       </td>",
"       <td>",
"        Days 15, 18, 22, 25",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"4\">",
"        Course III: CNS prophylaxis and interim maintenance (12 weeks)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cranial irradiation",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        2400 cGy",
"       </td>",
"       <td>",
"        Days 1-12",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Intrathecal methotrexate",
"       </td>",
"       <td>",
"        IT",
"       </td>",
"       <td>",
"        15 mg",
"       </td>",
"       <td>",
"        Days 1, 8, 15, 22, 29",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Mercaptopurine",
"       </td>",
"       <td>",
"        PO",
"       </td>",
"       <td>",
"        60 mg/m",
"        <sup>",
"         2",
"        </sup>",
"        /day",
"       </td>",
"       <td>",
"        Days 1-70",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Methotrexate",
"       </td>",
"       <td>",
"        PO",
"       </td>",
"       <td>",
"        20 mg/m",
"        <sup>",
"         2",
"        </sup>",
"       </td>",
"       <td>",
"        Days 36, 43, 50, 57, 64",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"4\">",
"        Course IV: Late intensification (8 weeks)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Doxorubicin",
"       </td>",
"       <td>",
"        IV",
"       </td>",
"       <td>",
"        30 mg/m",
"        <sup>",
"         2",
"        </sup>",
"       </td>",
"       <td>",
"        Days 1, 8, 15",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Vincristine",
"       </td>",
"       <td>",
"        IV",
"       </td>",
"       <td>",
"        2 mg",
"       </td>",
"       <td>",
"        Days 1, 8, 15",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Dexamethasone",
"       </td>",
"       <td>",
"        PO",
"       </td>",
"       <td>",
"        10 mg/m",
"        <sup>",
"         2",
"        </sup>",
"        /day",
"       </td>",
"       <td>",
"        Days 1-14",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cyclophosphamide",
"       </td>",
"       <td>",
"        IV",
"       </td>",
"       <td>",
"        1000 mg/m",
"        <sup>",
"         2",
"        </sup>",
"       </td>",
"       <td>",
"        Day 29",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Thioguanine",
"       </td>",
"       <td>",
"        PO",
"       </td>",
"       <td>",
"        60 mg/m",
"        <sup>",
"         2",
"        </sup>",
"        /day",
"       </td>",
"       <td>",
"        Days 29-42",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cytarabine",
"       </td>",
"       <td>",
"        SC",
"       </td>",
"       <td>",
"        75 mg/m",
"        <sup>",
"         2",
"        </sup>",
"        /day",
"       </td>",
"       <td>",
"        Days 29-32, 36-39",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"4\">",
"        Course V: Prolonged maintenance (until 24 months from diagnosis)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Vincristine",
"       </td>",
"       <td>",
"        IV",
"       </td>",
"       <td>",
"        2 mg",
"       </td>",
"       <td>",
"        Day 1 of every 4 weeks",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Prednisone",
"       </td>",
"       <td>",
"        PO",
"       </td>",
"       <td>",
"        60 mg/m",
"        <sup>",
"         2",
"        </sup>",
"        /day",
"       </td>",
"       <td>",
"        Days 1-5 of every 4 weeks",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Mercaptopurine",
"       </td>",
"       <td>",
"        PO",
"       </td>",
"       <td>",
"        60 mg/m",
"        <sup>",
"         2",
"        </sup>",
"        /day",
"       </td>",
"       <td>",
"        Days 1-28",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Methotrexate",
"       </td>",
"       <td>",
"        PO",
"       </td>",
"       <td>",
"        20 mg/m",
"        <sup>",
"         2",
"        </sup>",
"       </td>",
"       <td>",
"        Days 1, 8, 15, 22",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     ANC: absolute neutrophil count; IT: intrathecal; IV: intravenous; IM: intramuscular; PO: oral; SC: subcutaneous.",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Acute Leukemias VI: Prognostic factors and treatment strategies, Buchner T, Hiddeman W, Wormann B (Eds), Springer-Verlag, Berlin 1997. p.677; Larson RA, Dodge RK, Burns CP, Blood 1995; 85:2025; and Larson RA, Dodge RK, Linker CA, et al. Blood 1998; 92:1556-1564.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_56_13198=[""].join("\n");
var outline_f12_56_13198=null;
var title_f12_56_13199="Arruda mapping algorithm localize accessory pathway";
var content_f12_56_13199=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F57692&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F57692&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 585px\">",
"   <div class=\"ttl\">",
"    Algorithm to localize accessory pathway in preexcitation syndrome",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 565px; height: 323px; background-image: url(data:image/gif;base64,R0lGODlhNQJDAdUAAP///wAAAIiIiN3d3SIiIjMzM7u7u+7u7mZmZpmZmURERBEREczMzHd3d6qqqgAA3WYAZlVVVbiIuI9Ej9a71uvd69/f34iI75+fn8/Pz6Nmo19fX+/v73oiend37XARcD8/P39/f4UzheDM4DMz5MzM+A8PDx8fHxER38KZwu7u/fXu9VVV6Kqq9L+/v0RE5plVmZmZ8WZm6613rcyqzCIi4t3d+o+Pjy8vL7u79q+vr29vb09PTwAAAAAAAAAAACH5BAAAAAAALAAAAAA1AkMBAAb/QIBwSCwaj8ikcslsOp/QqHRKrVqv2Kx2y+16v+CweEwum8/otHrNbrvf8Lh8Tq/b7/i8fs/v+/+AgYKDhIWGh4iJiouMjY6PkJGSk5SVlpeYmZqbnJ2en6ChoqOkpaanqKmqqwGUrauKr7CzjbKRtrSEuLm8uq69hbvAw33CtcSCxsjLdcqLzszN0dN30InW1HDY2dxk24bf3Wrh4uVb5IPo5t7r7WXqgfDuX/Lz9kr1fvn3Wfv8/wD87REIcArBgu4O4lGI0AnDhuIeSoOIRiJFOC1IPHjAIgYAFA9UUMnBMY1AGy82vrgA4MIDD1NcbmSBxSIWlCpZuoQpRcZG/44iM9m0gvPBSgAsHrSoIjOoORUoagi5IONjyCkaS1bUorEEgBYvWr6c4mGphwcsrQy10vVr2J1TXnj1mRbTWiptwSJVSqXFA5BOy5X468Hj3o0wZaIFoDHr0iKDaW7NAlJG2sE/VcSoMfPrAxIgwx7xybPKXSqVL/8Mubnz2ayli/h8bBdP6qk/SQBoXfI14iI2UFwA7M7nT5bE4XK20TU4CiORTWqJsfrt2MG6fcbwS5OuEZle1eah/tM6TOwAtJ9lqTFHEZm6NZ2WQl7l3qXo1S9uP0RFjarEzRPDWc8Rl9RqGT3gVYBDRDeZFiV4wFkOcCmGGHdixaZCSotdMf8fFRFOWOFqL6133xEuVSWUHiE+kENSS1lY4mIwDiHjVea0wIJXwUkFkg1iqShEVyRJBZlWZ/izoWEa2ZAiAOgNgWFKdVmFgmEe4rHkkA84+UBVUQqxnn8KNvgCkE+uaMeWjHWZlEdhAjAmZ+EVwWA5NkioEpq/WViCRiDVUCeXPw06hkAecEjCUipkpRlnG13gF0hf2rnac+LhkehGiwLQ6EaPHkfgRlh6yiFQ8mmqKH4g6cYbWqM+UCoRd17EpaHasIEhO4qYeMqHYvhqaxRt0QGslEiKcWwYwpay7BfNDgvOL9IeWu21AVGLLT3bSvvsg91y8W24o4xrhrn8oEv/7ifqWrvuOe+yEcC89NZr77345qvvvvz2Sy8U4fgr8MACM7EswQgn3C8jwCrs8MP3ctJuFwEDbIc1BxfDsHR/TMzxMU9UPBE+a3ichMlZgssHyuc+IrJDFxtcssbPfExzqo683ATKGM+88sYqDySxyxaHrIUBAvU8zhEOLHCAEAMEwAAAAyxgABIGEAAGy6bZLIQC9EZwhQAKHIG0QUPnXDTMREQ9gBRnD4F0AFrT+7bMS2R8xAIJCCFAAQAIMO/VZmvNbc1BK4AA1Qs4YGzaWcSdq9GUD+E23LhIHgDheJO89BENlA0AAQIMsTnWhhcxQAHzNgAA0kj3vTPQSRqh/zgADEgd+LwEMIA0AQEsEEHrACRA7+JkA6AA6wEsfrYABABfwNPDz1t6EVzz2nYAd0MhueVWIyHA4l7o3DnU3MsNfAB9I0Bv31n/S4TmnOd9fu1H5H6AAU6bXr8Q66PX9YQQAbExwGpIG6AQ3Ne8I2QPbYmb1wJKd8CpNSACsBtd2YxHBOMdIHkKKBvSBvA8AgzgAHwTwALepgAFCuGByjLC5aLwvd2d7gjjOxzbdoi+7vENAE0jAgIAN8HXZU4WN0TfvLr3wvu1DAkFGB/5Xvg/9R2BALJTQAJq6MRpJQ4BByiA64xHLwLErYVGLB7zuAfC0rnteaLDIgLIh0bsQf/OcukTQvzYBwAG8nGPwkhiEXIoQ+a5jmyCY+LJ1ja77d0tavUagAp5d7ka0o+HSNAbDgkQPv+h7ggFxN3muGg/xOGPCLerWgIqKLdXoPFsBHCdA9hYNjS+sRXJG10CoHeAA5DOCDAMwy5mCIAfBnEIQyxm6UgpSKrdq36hPKABoPe/9cmOCOYrJR59eM2oOa4BWiui4IpwyUZ6zmtEOADdhiC4eU0RgPZS4OqIR8pzXgOdtzPiNI93xmXikne0VJ4buQdHACYgjLxzYbY2Mcw8QtJuk6RbJQNZRb+9cwhY/NouRYdJbZpTifNSwB61Bja6aY2MrJsf7wKyxI9m0mf/QjPlE+vgy2ua7o49HMIP0ffNcJZunMCsaOAuSkADbi6XHbVnF9+gNHRWg3YzlQO9OIpNnDpzqiNVHu9OOq+UEqGdDcSjveo3zwAckqpLfWnl5tDUoD1Vpu8ARDC3RrS1prUNbT2lHuZqV+3dTE0gS+oiRzZYp8YMrn79GUPrKli1Ps6jes0DXxtL145Z9Z59VWoc8nouiHkWYVB9x2dHS7DLIiKb+CCtaud1V7myArPZmCwjW1vZqHoxFbItLDVyS1lgwjSusEUFbx3YjaG0swBTa6ECUqdDl9rWXad9bXS5YZPcTQ0BtSyAIss32+fGMLi/Am80bJIAw2VNoImF/6x3hRkL6R5iuHsVg3UBEIFaKpS7mU3vd6eLW/Eyw7hdTe59KdZd4K43Ge697W4Z61wDO1jB4eXvgtWWX+g+OBgJxjB1GUzb5uo3HRn2xYYp3NvaXljE/ZXwNIBFyP02+MMmhrAp4GvHETNBnZz7JQCiaLuwEcGMAGjA8XppUyLMMgqohbGHNZzi9xb3CREgH9L2Zz3bLa5qjnud1pr2NgZo9wDLdWFJkVxgJeNXxTP27zK+0bSnIUBsX1Po7ebbx9I1rYoMiICO9UiOJFvYzJZVBY2rauMmNA6FnKsjKiV4PXU+LXCsK+L2OFpP3Xb4zCcGsaDVjIxwXLC8qJQzGP/F6Dc4E+GAWc7zntNYZse6lb2cFsWgb1poJuSOx0NQdK6v/MMCZHl8T5MmmFfNZzJX2MWA1keINR3bKLDubnNbJyqlHAAVym2NpTtAkb/2vmP79nMHjseyEVzrMDTAdeH+tmFjzGThxnoYs3b1pQkc2XZH2MnlfneN171kFLsbzf/lsHozzW5/31vGASfxi//McIOnGeBrFrhmCd5vZv8b381W+LzF9WpyNxnhEdf4wJMNL32zy+S8iDdxvV1wWEO8XCjPxWpn/tlWI7vhFj+4veNF6MPyG9Mgh/nL48U1TVLctZse+ruK/luSK/bjO+d5E9/6c3orHRQqV7lpJ1f/dY7HfOtIlzoALJCBqVvAAo/tesmvfnK2X4sDJgABBgKgAxAEAO1sbTrOPX7xoJNrA/baAGHHQPapZwDvNwdE4Rd6eJ0rvuyMR/y7LGAvFwxeDBwIgNwDgAG7c8Dpd8j85jsfgM8/fBCinzvpTc9zu88LBz4vA+DrJXjQ32H29Kr96QeB+3npnuc6oBcGYk+GDNgL8nv3g/HrhXxnGWL59Go+z08QABOwPu9ocL3m090H7YMA6oLwvtiHcIMA7IDqZpj7vIZ/9D6on/PgD8T72T/+zEse+2gwQfXrPQj9myDphuB/40cElod+ZhACARAC/CcICKiA8RcIDTiAT3cG/5R3f4knCBUIgIWQgRIYX2pQgNznByDYd4Uwgh1ogBJ3giOnghknCVoHCy/IgigocjJoaTXYgrdwgwung1RAcz7oMDYHTD8IMTsoWkMIhCnYg0e4hA8DCTFIayXWc1JVhLZXhcq2dpbwhFAYWiu4cvg3cR0nL07odZeghVMXWFQohZuVhheIV2OIhZVghgsVBRXQARAgAUdQh3cYBhIwAQAwAXiobmx4hlQgARpAhmC4gGBAARDQhX4nBXJog+1lBBUAARWQBDPgh4xoBJk4Bn34h4G4b4M4h0UgARBwijBQASMgAqcoAikwBB1AAYx4iAAwi0JgiqgoAR+wAkJQif8jIIqSGIZCMAOnCAEawItLsIlHoIzB6HZRyASAyASMCAEUEAbRSI3yhlgAUImXiAQwgIfMOATf6Il+GI2CuHHCMAMd8IsVMAEUIAIzcIu0SAEdUIunyIsaYIwAoI7s6I4f8IoAIAEicI7Z+HM08AGXuIrdqAThSAQNSZCTqAXKMAHFCANCYI5FgJEB6YdFIAKhCAbXWI1eiIZDwI1DQI+nmAIpUIzFWI9CsJIpSY0QkAK4uI4BeYo2KQQrAAG/OAQfQAMwqY+fqJFbiI5H8JMdyZFEoAHgCAGAuAIfIAKHiJRE0IkA0AEfSYjNmG4HKZK9yIpC2QEfAAEisAJ2CAH/HVCJrbgCDwmM2tg1SDABh1gBVBmXH/mJRfABXgmSeIiNI8mF22iJPvmKBwmK9mgE0ciIeDgCH/CLMwADjOmYFjkEHlmHKcCYRLCSKzCUWamVjuiWACCYRDAC+eiUv7iTvMiIKYCVGiCXobmQQjACEMCWuwiRtqmIQyCQEPABeAgDc9mYEtABK2CWEtCQlUgDbamGb9mDSeCasvmL0YiLTvmHYKkBaqmPQlCaWAmIlggDawkA3kmWyAgAO9mTQvCTpTmThumXt4lxRGCSgcmS7diUiEmfABCUaImfLjmMvkkDWGmRKQCWlsiZf/mZygkA/5gEGjCQEjCZjKiHI+Ca/wnakYZIi6DZnu03BIzpnyxJkxwpl8oYocWYAslZlMsJQUdAkbsZiIAomzSwkX+oiQOqlEOAjcFZjQLJix6ZowDgkURQmR1wmR+wlAMZkgXpX/CJoAB5kU05nkx6mAAQmRramEfAmPUIA7x5lfFIAzNqmBh6oQWpjtXYju8IkK3Zoy9qjxUwlIcoptvojgEplntpogX6c4bIi4xJAb5JBJ9IlyQ6mwCwoOQ5kyXqmRHZD815jPDIpKt5i+WIh9yIl0RgoxyZnsZoqRa6j/35nwE5lmi5nnNKp0jKku54lvUYjSvAivtpmMwonYfoqnmJh1x6iTXZpURpqFtpm+lpnf/E2IqqOKRC8KBD4JqBWozWOaireqBfmny1KKCQKqBrWpHkqaoUMJZ2+KcGmnMpk6K/+YotypPg+aiBuaYDWQSUeotlmZvpagRWCp68eZz7eKp9Gaq46oxhN4rwMAPxCHRHiptOIKk18YYSmajBSo3RqJ3iyo2MiZ1CcK5CEJ7qCbFLep6yKpgq2gHyGpr0SoqAaa9+JoYbV3FQALDbSpIlKwV7eq8d655GmXaJGILCGHVwGQUqKgKw+Vcr+4hgWqdugA3mYjJyeBCR2K8se6joyIQJM4r0gLSglYQomoVOyLRSKz/PqLM6KLSAxYOimrNaK7RT+7X6orU7a7Riq6z/ZQsMQ1uvYpu2ZwuzVnuDbNu2Vihucmu2dasFQuZOj3YF8bNTAVQ27rMAU2MAgCOyVnBkerQAdDM1WtVACDU9gYNuA/sHxzU1AcQ+BxRWCpBlWHe3YcBluKNdWVBEU6ZLQ+BoDbA4ItVyVjBmQlBEDQA4vIRlDgA4BXBQBLC3iOoH8/U3p8Y956ZOJIRWnhC35XBnRVA90wM90tNLJbUAR6BO19M4o9NVAxA1B5C6CUC8cHg0r6A/aRQB6NZCCWC7CYAAAzazfDBLUwO+X7M4CNAAwgtksua5YfA3wfNTkBtF0HNCfFO6SdBOisu5YSQ2gcsAZsQ6kIuIWxA3Dsw9/3WkOI+LwPwTVgH7B9WjuI8GupmLAAkQAWS0bThjv2GAan7UPLmUUUImaUlAZ35DVedbvjsmwpnSBXEDvmcjvnEmROcrv3l0sn5gbQCkUCZEAA7gAMwFdiRMBcCGO1bzN3ubwteUOwPAQYUkQgrQS7gGAChUxbbLuZNrw7IAu7Kbu1hmRfHraLsLCPxzPSqku0M1OkdcuMW7xDaMbQT0PlIcbYtjxUNARhHwNGWVxezkOo8LxxfMBSX1R4rbO9xmwcrjOB0cxn3AQI3GwkLgS28Twp1rxzKnLXdrvJ68xjlov6I8ykBMg2d7yqisvgIbyq0Mg6Bct6zMDXnbPIg8Bf992zdlhW4H/Dp0bHVbUD2EfMJOrLlgzK96IMDwsz6uM8mRXL+xfLgrFLrbNQWkGwAHEEoDYMSoq7pClchawEvK4zpzRATBS1Dcy8B6oE49tWOyBLw+PLxCN81UgLytxDqO3E77TC+Mm07V9rq1C2fii73au86knAXg9DS+y0BAlsbcQ78u1wcEEMgCYMDIlTUHANHdHM4jbM9TgL/ZPDUFxEoXlDseLcAB4AB7tADmHDwUrMC5XMNaUFYLEMwIAL0d/MGcbLh28DfLdTWE6z4UpLgeDMLzQsO1AdJXgGpxAz1kxDug1gQurEwd5MHmK8xdEEqtVARFfMRJ3L15gMP/2ky9KATGX43EnczUUdDE0hQ3BYAArCQEKI1M3Ls6VKUA/ZPJKyTDvqbVWyA4V4NcfURVOWTEtcu6dpA7juNBLu3EnHvYc7zWbP0EhCtARmS9NtRAYMUA2FUEgCzIAfZVhizTgI0FwJNR9DXamWxCxZPUiv3TEgQ/imtWp+vaPV3Hlc23L8i2tazEu80ElcZ3r0zLwV3Ppey5v33cPMu1PLjczD22X8eC0B0N0aZd1z0AofPH0KsEu5zHAVDMMA3ME13TJXU1eevI0Ly5bXgHldtKRY3M0hzdSzBCyoNB6aMAEUDFXyO5SJDNH5S75fzNyuPRqXwFBLDA9EXSYpPO//Tc3nXQu4WbuaXj4AaA0B9N31iTPtTE4VrDY1Hzz9Eb0MXkAAsNaQbtwRguzlnQZqBjwPMs0bFNB+wrSgegSr/E0TLedhqeBCMURgjw43ENaYGz4jY0wDYNOAecwAGg4GJtBRHVSa9TzTuN1Hzk03WQwVLzS79U5bndCdXNDNdNZV31NOqEwEptBFXN1UIQw1l92lAuOuDU5o7s1d0M1jPu3nwTTz9252rN4z1uNj9s30QQAQWw10yA11+VRF3s18mc0Fhg0oCzPIgs2YmN5XbQxj+mQJYezMBN34RuRIo0S0R1BKENT6rtN6Xd5DNN0+McYA/VUlyM27CN6XNgyf9ePUCa/NpXrtuBnuFO27W/vliTEOZlOOzArspla+zR7dskzOzM7eymjOxZW9xyC+3HLe3KTe3YQ4QvBLZVK7OHArZUaxDebjDnTrTiku6mQe5hO9091zDh7nAZauvq/rJ264inIQ/+MDFax+9bm+ccG+wCr8wsl6sBr+9uu6whC+GBhqLyrrTaWu8GP+/5nvD4vu+uzJxTGAcu7ky5Uy8r2GJeqAw//OQM/7ZGgGMYJQBgReLNzQRatPGtRvIMD/D4bgTb3eZWUy/r7Awzf+8S70DXbGxxsFO+2+sjX+pQaPJF7+oIb6/JS20BPvQaRfMVZvPSrbYKDwX8Xc6hTrT/QR/zB28wT1/2X+BHfbPzv6T0iaj18X4y1/ze7EMATL/1A6/sRhDVi+PibxY4YU32SjD2kAj17HT3eS/4uWoN6+PIIC41YR/zhI/32Zo3Z2/xXpBM+sM/T1Mv6euZsT44JW8EJxzev3tdZRMAptbmK4X32v4EHlTiiLbZzoAOUV3uaF+god9MXC+qZBT4XP8NsUTkyRNtvG+ot89aKZ/zSlD6Rs78YBBRhhNF5xwQaW62cN/0cr/35lU3Bn7xve+M5Ws3QQbChgM9Vq881w/9/Zr94Z/4RQgNG308XLzl8HPykq/U/d4Plw8EAOGQOAwUkUnlcjkIOAANglBAWBiE/4EEk3hUChBML2CMDAyQjAADEFGQsVyjPEu33/H5ZZlLaAAczgDUCgSopuT48BS29OocH5PAxOwU7yy7uBICDgAKwtoKFjoNBCmXGPcgizDzTFfJYGUVAgIIEA9sjRoTlyZVI4cQaonfiARqC9gC4uhaWWWjpXvtkG1NC0yrnFdTIZ+piZyIa5szub+5wAeybUEDQUvRTpW8k8ArYYfJjdOn//05GoMPYCx0BRHKIohwIUNYDc3kC6gE4sNVFSkmnKiRI7SAGBVK7DjyIMlzJj1uxLMQZLB7KFsaDIkyHE2NMQfalKlOZ8+dNGPOVHlJpB5wQVdelIYUIFOf98hFlf861chUq1exWi36lKRTo1nBhr36UKxWZ2Wp0huJNq1Ctm/ZcrXpNeNauTDvznGI167SvHSJ8s2rE3DEvoM5FvZbUDGwjkEbG+0Z+SXiuY+7Wk6MuDFlw5gXy/Vc1+RozScTmjb9l3NqoJlDc12dEvbp2q4P2/43u+bu17klsyb8Wzfom7eLR+OdxEKGRxksyHIR3eB04LiHomz+nLrG7QahJ/zuJXxyxsY3m18ql0MAEBgCYAARgIMsC+51xMdhAjl2gVzbey+++erjKED45KMvoQMHVFA939JD78HsaNogqg2k4SGqHfrbi0KTLCQHw5FCJGbEhEqs5cQJlZPQPxb/g+Mqg6ici8aFqLqLUMcYfZqRnBo78pEYIBESshYiYYztvOuS3Mqn+WoB4Z8TiOGhtA4D4wpK91DaUsqOvGyyxR1fFLOkp+CrBYN/biDGhSuZzBJNYtY0Kc34RrqzTjM/HNNFPtXiyoQA+PuHg0FPEIzMpO4atFCUHDUpUkD7FGpRSiu7K4QAQijIwhsUPU7JnjbtlKZSTUIVUx49vHRV1Li6L0dpLDChQCybsuguWW3ilSRfX5WzVVGDJe2uNxHSgThXz3wKWZueJSnaYntb8k9qf8L2sjid1NbbCT1T7VtYx8UVwkrLTfeucM0NdrlyxR1V3XmFI5ZZd0uDSyqo//QlZ5p40W0qLuUGFqjgb9nlttjVmLKk4X/b5WnbblmV+D9htU34WmoZ9pPcigPWNWQ5Sqk20JFxYnRcje99tWNL9RIZ5jJVHsKJefAo2eJmL6aYZ8cQ3vjclZkQYIFaIujEmgAKQIOBdgrg5aQEOimCnVq2uLqAqh1OYgAsrtZCCFoIYMMleXNV8mY9dD4ZAHs+BvmVuHk2ABHavGXZ3qCVCCTrAiIAYBtP/ijgD8FBSSmBBSLAuY3AAzmggTAiMCTbnxiI4IrHAeHEgSkECPzskUnHG4C1hbAbawD2EVv1WkyGO2aZjXB8dleSsDtTvvemGdtWIjgcgFIO2OYAAv8MKaAfYwUnIAKzF4ACjsnbsLzr1BUoZIjoszDgc8FFv7znlk9GHYAFtnBgASIQKOB8Q9oGegjZR5fb9vrrvptufMmfOWNULHe6MywNFAzYhwLMZjrWMQMOWUiA1rhWmU0krnsOfJstEugVgI1PCKgbBzEGYLRaEGBt8TPWJqKiQB61rhbLE9+ZCBCVAL6Qf70bVt6WELwhEG8b7UOCDz9ziOcJgXsNDGLMDJC9ABaRgbujne+cZD702ewJUZjCAgyBjNhJ7XZDmVsXMTY8/YGRY0KDWLpa4bfTfaJ5QmBj1ISAABdGYnGNI0IEIMcJJ7okc5vDY+eqdkS0Da1iHwz/gAJeNwVa2GIKKMzGFvfIwSzcj4Y72+EY8VdDKBISh744WgBEN7gBIK8BxGhapqiGhLBxEYyW+NoaV8e8QZ6xdP6jXyW79cVMWjKG5JjhuyZjxvWgkQ5TnCXPHjZMYbptmWTEXRh9Fsky9u+J/5MDClkZzVx6rJrWkqTCBPlN+dXMZNO0oTd510y3JZObmywnNXH5M1lCc57mdKcyidaVfvnLDPskBi3hGc7HHOwiBF2JQX+nzmOuCphKMFVBHhqxdpITFVizBgX9N5KIgjOdN/RoQrsxw25m9J4TpScSFGA5AcxxpAFtaT7PmTZ4teajJSWpPFGqUpYuFJ0KXZhP/8VpTySgMABhyB4gFsCAlB5gkeur5TtrykmKApAKO33qS2VKr13eFKAdVcImOgG4zaWUeFy9Ksh6OtV66DSroQIqoDIQgugcwQIhQNIq4jpXANT1rl3t5FfbIQgnHC6lUQgAFnn6TDi91Zk5rWpbF6uRDNygPkfgwA36ii0qWchCiZpSADgbAM/alFLP8EPn0AA4BhZWCGqgJE4Ta1LIqhWlFq0FRvWQgRNgoD0cwMAJMhvVaZjABJwl7rw2RY6NyiK5xFiuVEH6hRGeQQGBM5pSBVCK28b2pGn1rjZHMh9HccmtCGluLZ6rrfaQ41bSWC8x2vvdnw6mM8uKKWzzFP+VPUnUPjiiV4lWNA0AMzZJDZWmWaE72+6ShEq1GG1kOTJgegkpuHgdEoFhZGCBItivwrUkqZw7sY7cqBbTShcOAoADjaBYxRhmkYZVyGF83heqJrlPLWbF0WlQ6cHzQpBGfuxicNFUvkWesWK5wtnh2AlPWhVCjwsCZQ8zlMgKJi13Y0yTG5lYx+49QXznlWOAiNnIVKbvlWWM5f1VKJjacfJ8Z3rmKXe4zOOkF4zfzCc8Q1g2aMaqbPHr1TwPmrZwXpef1YxktKprz4TOMKOrnOA5/9nO48prLPjq6G/4sy2c3leiCywX3VKWPjcArnRwwNtSn4DMshh1b01d4dz/noDUlz21otW1WdCKVtNnzRRgIANpuYiXUOSVBZUGVQsraYTYg/oSQJpt7EJfwtOctsN5OUXtapelOIXJiaRr7LK73ElN0iB3ALg8jXPvV936Deq0+ayE99YCzJV2aXlFBmxKlzYvDea1e5P9b474W8rSILivt8pfAEgYvHVu87n0DepHayrEAqaTRitu3ozj+t34TgKF4e3wJScBAYkzn2NaQQBeLC18Gw40pvb83npD4sa2GonMNYLzjje8y0JgMceFHNOSU/G1J0n5yqcwSpE2NtxmvouSoR0ADpEE6hqp+qIp6sshlJKViwTlEHJxN2IQwBwJH0KQF0wFU6KB/+Vp90krht5BXX7m6EMYXARwa/Z6CtVZ6C5IfloNkC2P2O8Iz5bYIgeAAyxAAXNUQBgGUEQBiCIOYjOay5NQcGYiYXCGa6PSef7wH5p87imp+yEGYUzMf9iaeQmwgNlMon2fzPJOXdzJ3xYGNZgNeXEXm2uzzBysH2MKx8siIvAe+pGPnujhOL3giJF3vR/Y0L0mZjtNGQcF/IG186sFYofHCQOMggxbQAAmN1i06KOeAapnvZxJTvqix+z5g9v8y/lt/Xk5RRFaaD8UDGmMHu8APG+BiGELxi6BmO7IvmAKgIiA3E70ioCFiOqQUG4JeqkW7M/e8A9QGk3/FI720v8nqSZPCBZPesYG8tDnBKnAfcRm78DN7hCBjTZQ+URMmSLO8NTjA0Ew6PqvEaogAAIIAVru8VJHC5xKgNQgm1zC01YP9U4HeWqwA2/QT3Jw55wuMbatC7btGboQdqriCz9t+jgwVJCi/5ZPM7xtAUOuDMWt53aGLrwwq0ajDPivXshQkN6FB4MvRq5w+N4w6HZCDu+PR+pwzWzwRc7wCa3s0GTqD4GO7yYtDiXtCg+RDZsOOBaxD0XuBk8u7IRB+mRCEeIu/JJhAHAPE2FQk2hMTgjRDWvmEvOQ+sywtpBGCFROlvaw26xmbiZvc1hHFL+NfRJHHt6mcUov2K7vWkD/UQgWp4UUMBgUARmAUGye8ZCikYb4wHy8zhCeJhm4yA4pghisZ4Sw4BoRyFjukA60yxaageucEZN6QxGMMPKgIBf3CBzakexMkWlQsfQYUQJPrvdAoRTpjvmOkO1IKBlnT8+w5BexIBeg4AAigJXEsQiQwX0AIIaopooo0iIDhRvDoBSe5nB+YXYwAfH0qPYkUvEqUh0ZMHcEoQE0cvEaLx5ZhR51bw02kgnRkAmMkSbDDw2qKxVXsc/E4RWIZ/w6wSBNDyGHkgARwCjjCRZhDksIUvGEUC2m8Ra8hxY6cun2ZxtfwQjPJwGUB2hScgsur/wGYQ22khIBjQiM8Y8A/+D2BCEB5NGS6PH7LAcf9ZAL6jJwjLEKqDIg09B8KDAYL3ACi9GUDoAqlTHO/mQpyS8BFgkBAgklOa/3KtIaM3MzM4ksccYIN2EADAgaaSMlk6HyzK+RQhMm53KHimEetu9tDEEvcxKlNLMAAdN09LE2o/ITDpMT364X54EFBcd9nNLooNIY5e61JhOmFmUxwa4AUaMrnWB9XtAEsbOxSNP7YkkYNJIz7yEB/i8LRkgBCVB4VjMmkUAebk+Axu4u9zJQdPJ0pug3ySU4B2A+23FrihMRn4IsySEJnSA1iaHshlEYyAE66bOFjPMos7B3lHPykogNCHDpLpL4qqf8Mv9U8bQny8IzBYkAjljHhTqUFUZwGXghRDdUNjksKLemBBUvenRT0fIz/F4HDLvIP6NgayB0QFUxDa2wETMx/1xkcagoc4ih5czTQ3dhACLgSanPQFvILIWglE7xPc/zEJyAF6jUSmWU0qCz8ZBHGD6THLdiE9fsTBHpFQzJqmYx3vINSd9PEjtRLSuRDnNjHUVjQnXRSCPtSGOwEAPx3nbnFSnUFf8UPu3LTYsUUgP1EfEUUSsU0Ra1T4dGFqsyTyN1ZnZRN8RwIL6wIc1ENbYwDKtNDE6VVUvVRz/VVWMVLVjB2m61Vs2iBwk1unj1r341WPOMD1tRWFPVWJFVq4j/VVOTlReb9VkFzVeh1QOntVqrD1itVUyWNVu5NQKptVu1FVzFdeIoc1yHzFzR1VnLNV2TY1vZ1Vzd9VLftVLntV6Rcl3t1TLidV65tKhEMxqq9JA6oamwoP2KamxQUDDbQe0OawuwSfFIiM70FCAirxkyk2G35i5X53jmL2wUQGmSoRMelmPZppcIa7sIkGmUxj2bICpQsR22IGUzVgBYNkkBNhkYwJDOwGBBQQES1hEC9mM7CBh5FmH1YEQv6GChT2U1VmxItiPUx2lO6R+qYGDdUygboAFy4WvoNCkTpyWlwBMc4HsEQCx10DxGwxrioGrtcfcIR2zJ1my3zn0i/w89edLzCmBsQUdumcDzAiGECCAyo8cB3CdqjudfuWAb/ihyCNcTqCZwI7EgotYTKGgbsnZrk0gWqvZt/kBtt1RrzyBzc0YDD0FwHcBt8VZvBYdvp0F9zCFswqAKYmhrvvHrmEAKlKY82yAMEAB0R6nslqABXMh5iidwCEBvIw9xz7ZdSyMOdAg3bXSlNhJ5yY8J9JJqSFAjpfd4Pyd5HaF9GMBuKJKwBAAtHRcBWBcJFm8LmMgAzDdq0BcQp8EJDKH71pd1fJcfYQF3l9MI4qB3t1Z/84C1njelovcNuJeEqnckJu+wDCH5Io8BDHN9bVQOwmYBNHITIpZnE2BNmf9wfj7plCZPAfgRm9B3GJJqNjM1NbTPch5PetvIhMHgsLKxgz6BcQTHGLZBhlG4hpfAAD5hK1lrALNBGcjuaESxCITSiLRAZhngiJWWCmEBjwpgaoO0tZC4gx/WES64PJuIgz14EVzYhdFXhxsJa06Yhk3i/zJQC2BY5cYURenALqFwCEgogbmgctwIAdSAFPSogxZScpI4EcO1K5yXfA9YHAKZepKggBsgkW1mkQe5CLjnBAt4hhAgAQAYIKkoDtqXfTTZdwnZEaJXI50AeO9YdWWBjpuICFL5e+6AgBFZe5dnlJxAkDkCDDqh/Qwg+ezOGACzh7oWGQyAHdCgAZL/EHGmt3GLJmMNRw2gAKzm54E4IWtV+CoNuXTb9m7dkxFu2Zob2X3aE3W7mZolp2aZYAH+4P/YtojECH9zQXnvqB8W94/feZPlWVBhwWjQAIjcgPPCgHt1l5RbuZWpIKDHdqC5gLXa+XS5mQi8uZrReRqAmE3DZoCAOQGWxvysKoZykSLNEewidouZIGhBtmF3SCN7+JqVVCMgMGlBwRoyNnVUWo29ph2EVqYDCYjjyKbtYPxq4WSj+G2goGgFkydteDyJOvWGGlQLYpGUIfyikWRJWg88uhq3ywRHWqmBsj5hGmN3uqZTOF8l7sXI2jb29ayhNa0pVa171a3huq1X/ziuJZCu7RpVC/muC1Sv+bqsz7Wv3xqwNaJfNbMgBmCRsMAapmhkI9aC20GoN4ex568NWzohZNpsKvoIZHZl8yBsTDJkmzZmGztnTDaS32CzBWeivQYYVwmsFyiFeRpTp8GkDRB2jNpnV7mFItNlb/tnBTOGjCmzRZRpabYnJvdpJtuqZxpspyBv49YO/miUElYonXtvDxWbNcJtS9AJEqdxDRdy8SC6j5ec4da6j/YP/na438C7Hzefj6EchKCeD4Cc45l6EMmpqRZyb9MgLzd0u1YONvc2ZTAKfFd07wCxiIe7h4C9D9e4gfEQjiZjA1bCv48L1GcziTd0llmB3f97CAAnvt0z+RLYeyX2WgEiENigj4WXCN5Xk9MXCT68DR6ZljecxPMAfMWXcuXoLgvXxV3Bk6WHGQ74mzP5v2eDf0twH/hxk39XFpC8PO+XyQWYDnLBcqJnxYegxePXJxoYsarW+CYvrMp2tIvmkzZnhEsYjWd4rH+4l9TZGW0BDXjYp/36QUYjYI+GqUJ4AJwYiif5kr7vkc04tNOYzdkxiOv3DXa8z4H6z5nYNWG4h2iY7IpYeWeji9lnfcC4qvEA07dUIzedq33h+55AAfac0ZH4KdjZGB6PhUrO0WFYCvo4/ALJlqvZ0d9HSgGZyFn6W0ni8vSYckGZyfUAiyD/eddvHQ8qGYuiYnkymdgTAci759jvMpN7vFEBgo7Drwhe+T7vwC5PGQm6PQ92L9jZSBhCeWtpQpdTzwCkt27DXAZxZseToP3YgCahWWMDKaLP2Q5MPTJPCZkh2pzBGa+bZDXGL4ucWXh0B58HeBTIe5q/WbWT4M3TM46Wp+FBt8ONSL4j/kb/s3B9u05XgZg9gQ3o/aCXWaHzwOTbYI4mQaA7PS3jHTs1Pp5pIrO3su3a4ACTdn1SnvNwdmlVL7ZXmgnGIapB2h1TuqcNfXnVVSP2IYBo22iNmg6S3mx0uulf24eVAKgDwD2DHrevftS3q7WXdqZTe7jVXp9h4arj/3votVrORf0O4F6qi4Cq6z4JUChp4l5g56eoU10uYBhZ2brXBVuuE9+l/7vXDj/NFh/yI9+uH9/gJz9yLx+wK7/OM1+2O5+uNx/qP59AR59t1i5A2WEIobSkdXt4jqZsmLpnR57kyKEgSVeyS5wVEUKxza/2Ubu49WCUdBi0cd8RSsEQXP33Kd5qWBtmXXulY9sqpYG2CTb2jXaKW18/46C3STuoYSns2Z6ze8IYq4v8KwcX3Dlx9fsPEAtrC7zx8z4Xzy+Bqnt1r7uyC4K5ieB4EgAIHAVAIXEgHADKJbO5PBQCCgAjwCA2iA4HASAQOMNhxiIAfhISQqIRKXYKAv8BgzISATgCh+q10DjoNSAAKNC9AQQcKi42CbgpZC01DDX8BQwYTDG+OSZBeskZVgJiam5i4V3aAQwQbA0VHSWd0ioaXHoR3A7kAtIlLJw2uAkUVCXdAiBYthrSOgL4MrlyDSzM1oolZnN3ezdtfysSRBwI3C1BJ8AmIJzVFiAgTBUrCUxRE1hj01onELzLBWAdG3e15ihZ4EDJnHpeFAwIhCCBqTfhxC0alsRhnUHLSOkSp9HLEIaGPl4KSQuBMQNICqCL0IBgEYMYue2CgiBnPAAyCQVUNCBKgAUFkgHYRSbAxAgJ5CTYZG3hrTJmBkJ1h6DoFXEXb4INy1BsmGL/ClSyUhgtijFdZQZtUjBl3kN7XZ4GaCdg64KujFqBAbhk6toAbQ283YQQkaG89+wq46qLLT8mX8kyGSrHqJKn+qi8TeAUajfNRUsyVrK0Kd6ojAzEu+py8x+2DNwyxWxLjuEDt+QUSOJgQURe2ewcS/pVX75NdKlsy2OclT6JGC/rzn4Ke9jkt2Y9ZzIR5fRDEXlLcfh4cPUDgk7h5X0m/JLxzBgtVstYfcV2NF07wZ12PqED2TStbNGFOKuY5ARzCW6i1gH6JRSQfaQM6MQuS2zIhFEVnRIHHQuAMQkTewFADWqHVOHMAlHlgY0CCUTkXiTfCJihjpYNWMVCTyXR/2ITLiljSWWL0MUHKkvMWGMl3AgGnTNKEInSkWEstkqMSvrxBHE0LYTljifOMRQvDQSTziAqiiPiEoupmeIrEWZBRpiEXMNhF1aOSSUufpYHQAN51UJAAGlQWQYBfh3BS2uMKFBgUoa+yGFJfPnlTY59ZrgpRnEU5VqkTiiw0GrZPAdqcJYqgSmUZ4zaRKmg5aYIqLmZ5pqq2AiQBRS9adOnoYgeEIEcaDWKFaHdDKsrb3BF89mjr1mVxXnGMDHrqZxy2212nnpLFrjhklvugOOam66667K7I7rtHgSvvPN28y699+Kb77r26itmv//iyy/AAxNccL0Gx4uwwuEKvGiwww8P3HDEEFPcacUXY4ywxABvnLHHb34cssgjk1yyySejnLLKK7PcsssvwxyzzDPTXLPNN+Ocs84789yzzz8DHbTQQxNdtNFHI5200ksz3bTTT0MdtdRTU1211VdjnbXWW3PddcxBAAA7);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Mapping algorithm for localization of accessory pathway in the preexcitation syndrome using the morphology of the delta wave on the electrocardiogram.",
"    <div class=\"footnotes\">",
"     R/S: R-S wave ratio; +: positive &Delta;; &plusmn;: isoelectric &Delta;; -: negative &Delta; wave; Sens: sensitivity; Spec: specificity; PPV: positive predictive value; LL: left (L) lateral; LAL: L anterolateral; LP: L posterior; LPL: L posterolateral; LPS: L posteroseptal; RA: right (R) anterior; RAP: R anterior paraseptal; RAL: R anterolateral; RL: R lateral; RPL: R posterolateral; RP: R posterior; AS: R anteroseptal; MS: midseptal; RPS: R posteroseptal; CS/MCV: coronary sinus/middle cardiac vein; %: percent.",
"    </div>",
"    <div class=\"reference\">",
"     Data from Arruda M, Wang X, McClelland J, et al, Pacing Clin Electrophysiol 1993; 16:865.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_56_13199=[""].join("\n");
var outline_f12_56_13199=null;
